• [Expert consensus on the diagnosis and treatment of young breast cancer in China (2022 Edition)].
    • Chinese Society of Clinical Oncology, Experts Committee on Breast Cancer; China Anti-Cancer Association, the Society of Breast Cancer; Chinese Medical Association, Chinese Society of Breast Surgery.
    • Zhonghua Yi Xue Za Zhi. 2023 Feb 14;103(6):387-403. Chinese. doi: 10.3760/cma.j.cn112137-20220907-01895.
    • [Article in Chinese]
    • 2022 : nouvelles pratiques thérapeutiques en oncologie mammaire [2022: New therapeutic practices in breast oncology].
    • Deluche E, Verret B.
    • Bull Cancer. 2023 Feb 7:S0007-4551(23)00036-X. French. doi: 10.1016/j.bulcan.2023.01.002. Epub ahead of print.
    • Review. [Article in French]
    • Testing for Inherited Susceptibility to Breast Cancer.
    • Robson M.
    • Hematol Oncol Clin North Am. 2023 Feb;37(1):17-31. doi: 10.1016/j.hoc.2022.08.003.
    • Review
    • Financial toxicity in BRCA1 and BRCA2 carriers.
    • Proussaloglou EM, Rosenthal AE, Raker CA, Wilbur JS, Stuckey AR, Robison KM.
    • Gynecol Oncol. 2023 Jan 24;170:160-166. doi: 10.1016/j.ygyno.2023.01.007. Epub ahead of print.
    • We All Love a Good Book or Movie.
    • [No author given]
    • FORCE. Blog. 2023 Jan 23.
    • Inference on the Genetic Architecture of Breast Cancer Risk.
    • Yasui Y, Letsou W, Wang F, Im C, Sapkota Y, Wang Z, Mirzaei Salehabadi S, Baedke JL, Moon WJ, Liu Q, Robison LL, Martinez JM.
    • Cancer Epidemiol Biomarkers Prev. 2023 Jan 18:EPI-22-1073. doi: 10.1158/1055-9965.EPI-22-1073. Epub ahead of print.
    • Environmental impact on carcinogenesis under BRCA1 haploinsufficiency.
    • Toyokuni S, Kong Y, Motooka Y, Akatsuka S.
    • Genes Environ. 2023 Jan 13;45(1):2. doi: 10.1186/s41021-023-00258-5.
    • The research landscape of the quality of life or psychological impact on gynecological cancer patients: a bibliometric analysis.
    • Zhao J, Kong Y, Xiang Y, Yang J.
    • Front Oncol. 2023 Jan 10;12:1115852. doi: 10.3389/fonc.2023.1115852.
    • Breast Cancer Advances in 2022 Showcase a Shifting Landscape.
    • Sparano JA.
    • OncLive. 2023 Jan 6.
    • Genetic, Surgical and Oncological Approach to Breast Cancer, with BRCA1, BRCA2, CDH1, PALB2, PTEN and TP53 Variants.
    • Subaşıoğlu A, Güç ZG, Gür EÖ, Tekindal MA, Atahan MK.
    • Eur J Breast Health. 2023 Jan 1;19(1):55-69. doi: 10.4274/ejbh.galenos.2022.2022-7-2.
    • Oncogenetica [Oncogenetics].
    • Suerink M, Bleiker EMA, Nielsen M, Houwink EJF, Baas JM, Ausems MGEM.
    • Ned Tijdschr Geneeskd. 2022 Dec 22;167:D6958. Dutch.
    • [Article in Dutch]
    • Ferroptosis synergistically sensitizes wee1 inhibitors: a bibliometric study.
    • Xu R, Wu X, Zhao Q, Yang Q.
    • Am J Transl Res. 2022 Dec 15;14(12):8473-8488.
    • Cancer Moonshot 2.0, health equity and BRCA1/2 testing.
    • Sorscher S.
    • J Cancer Policy. 2022 Dec 8:100379. doi: 10.1016/j.jcpo.2022.100379. Epub ahead of print.
    • Letter
    • BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy.
    • Choi E, Mun GI, Lee J, Lee H, Cho J, Lee YS.
    • Biomed Pharmacother. 2022 Dec 6;158:114090. doi: 10.1016/j.biopha.2022.114090. Epub ahead of print.
    • Hereditary breast cancer: syndromes, tumour pathology and molecular testing.
    • Sokolova A, Johnstone KJ, McCart Reed AE, Simpson PT, Lakhani SR.
    • Histopathology. 2022 Dec 5. doi: 10.1111/his.14808. Epub ahead of print.
    • Germline pathogenic variants associated with ovarian cancer: A historical overview.
    • Johansen EL, Thusgaard CF, Thomassen M, Boonen SE, Jochumsen KM.
    • Gynecol Oncol Rep. 2022 Nov 8 [eCollection 2022 Dec];44:101105. doi: 10.1016/j.gore.2022.101105.
    • BRCA2 gene mutation in cancer.
    • Xie C, Luo J, He Y, Jiang L, Zhong L, Shi Y.
    • Medicine (Baltimore). 2022 Nov 11;101(45):e31705. doi: 10.1097/MD.0000000000031705.
    • Classic and New Markers in Diagnostics and Classification of Breast Cancer.
    • Benacka R, Szabóová D, Gulašová Z, Hertelyová Z, Radonák J.
    • Cancers (Basel). 2022 Nov 5;14(21):5444. doi: 10.3390/cancers14215444.
    • Reducing the risk of breast cancer.
    • Pederson HJ, Al-Hilli Z, Kurian AW.
    • Cleve Clin J Med. 2022 Nov 1;89(11):643-652. doi: 10.3949/ccjm.89a.21113.
    • Characterization of Oncology Clinical Trials Using Germline Genetic Data.
    • Kammula AV, Schäffer AA, Rajagopal PS.
    • JAMA Netw Open. 2022 Nov 1;5(11):e2242370. doi: 10.1001/jamanetworkopen.2022.42370.
    • DNA Repair Mechanisms, Protein Interactions and Therapeutic Targeting of the MRN Complex.
    • McCarthy-Leo C, Darwiche F, Tainsky MA.
    • Cancers (Basel). 2022 Oct 27;14(21):5278. doi: 10.3390/cancers14215278.
    • From the patient to the population: Use of genomics for population screening.
    • Mighton C, Shickh S, Aguda V, Krishnapillai S, Adi-Wauran E, Bombard Y.
    • Front Genet. 2022 Oct 24;13:893832. doi: 10.3389/fgene.2022.893832.
    • Overview on population screening for carriers with germline BRCA mutation in China.
    • Lei H, Zhang M, Zhang L, Hemminki K, Wang X, Chen T.
    • Front Oncol. 2022 Oct 24;12:1002360. doi: 10.3389/fonc.2022.1002360.
    • Aetiology, Epidemiology, Histopathology, Classification, Detailed Evaluation, and Treatment of Ovarian Cancer.
    • Zamwar UM, Anjankar AP.
    • Cureus. 2022 Oct 21;14(10):e30561. doi: 10.7759/cureus.30561.
    • Identifying the current status and future needs of clinical, educational, and laboratory genetics services in Pakistan: a web-based panel discussion.
    • Ashfaq M, Ahmed SA, Aziz-Rizvi R, Hasan Z, Kirmani S, Munim S, Naeem R, Raza J, Furqan A.
    • J Community Genet. 2022 Oct 20:1–10. doi: 10.1007/s12687-022-00615-x. Epub ahead of print.
    • Breast cancer: an up-to-date review and future perspectives.
    • Hong R, Xu B.
    • Cancer Commun (Lond). 2022 Oct;42(10):913-936. doi: 10.1002/cac2.12358. Epub 2022 Sep 8.
    • Unpaved roads: How the DNA damage response navigates endogenous genotoxins.
    • Thada V, Greenberg RA.
    • DNA Repair (Amst). 2022 Oct;118:103383. doi: 10.1016/j.dnarep.2022.103383. Epub 2022 Aug 2.
    • Review
    • Mutation Patterns in Portuguese Families with Hereditary Breast and Ovarian Cancer Syndrome.
    • Vicente R, Alpuim Costa D, Vitorino M, Mendes AD, Santos C, Fontes-Sousa M.
    • Cancers (Basel). 2022 Sep 28;14(19):4717. doi: 10.3390/cancers14194717.
    • A bibliometric analysis of the top 100 most cited papers and research trends in breast cancer related BRCA1 and BRCA2 genes.
    • Alkhayyat S, Khan M, Ahmad T, Haroon, Tariq H, Baig M.
    • Medicine (Baltimore). 2022 Sep 23;101(38):e30576. doi: 10.1097/MD.0000000000030576.
    • Getting Past the Shock of a Previvor Diagnosis and Making a Plan.
    • Swirsky N.
    • FORCE. Blog. 2022 Sep 21.
    • Breast Cancer Genetics: Diagnostics and Treatment.
    • Criscitiello C, Corti C.
    • Genes (Basel). 2022 Sep 6;13(9):1593. doi: 10.3390/genes13091593.
    • Who Should Consider BRCA Testing?
    • [No author given]
    • My Gene Counsel. Genetic Journal. 2022 Sep 6.
    • Call for action: expanding global access to hereditary cancer genetic testing.
    • Bychkovsky B, Rana HQ, Ademuyiwa F, Plichta J, Anderson K, Nogueira-Rodrigues A, Santa-Maria CA, Coffman LG, Marquez C, Das A, Taghian A, Koeller DR, Sandoval RL, Park BH, Dizon DS.
    • Lancet Oncol. 2022 Sep;23(9):1124-1126. doi: 10.1016/S1470-2045(22)00378-3.
    • Commentary
    • Living with Hereditary Cancer Risk: FORCE Takes Another Step Forward for the Hereditary Cancer Community.
    • Steligo K, Friedman S.
    • FORCE. Blog. 2022 Aug 25.
    • Investigating disparity in access to Australian clinical genetic health services for Aboriginal and Torres Strait Islander people.
    • Luke J, Dalach P, Tuer L, Savarirayan R, Ferdinand A, McGaughran J, Kowal E, Massey L, Garvey G, Dawkins H, Jenkins M, Paradies Y, Pearson G, Stutterd CA, Baynam G, Kelaher M.
    • Nat Commun. 2022 Aug 24;13(1):4966. doi: 10.1038/s41467-022-32707-0.
    • GeneHome - a Novel Model to Deliver Care to Individuals with Genetic Predisposition to Cancer.
    • Nocera Zachariah N, Lee MC, Chang MD, Moore C, Wang X.
    • Cancer Control. 2022 Jan-Dec [First published 2022 Aug 17];29:10732748221109951. doi: 10.1177/10732748221109951.
    • Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendations.
    • Chung C, Yeung VTY, Wong KCW.
    • J Oncol Pharm Pract. 2022 Aug 15:10781552221119797. doi: 10.1177/10781552221119797. Epub ahead of print.
    • Review
    • BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside.
    • Boussios S, Rassy E, Moschetta M, Ghose A, Adeleke S, Sanchez E, Sheriff M, Chargari C, Pavlidis N.
    • Cancers (Basel). 2022 Aug 11;14(16):3888. doi: 10.3390/cancers14163888.
    • Decision thresholds with genetic testing.
    • Felder S.
    • Eur J Health Econ. 2022 Aug;23(6):1071-1078. doi: 10.1007/s10198-021-01410-0. Epub 2021 Dec 2.
    • Health equity in the implementation of genomics and precision medicine: A public health imperative.
    • Khoury MJ, Bowen S, Dotson WD, Drzymalla E, Green RF, Goldstein R, Kolor K, Liburd LC, Sperling LS, Bunnell R.
    • Genet Med. 2022 Aug;24(8):1630-1639. doi: 10.1016/j.gim.2022.04.009. Epub 2022 Apr 28.
    • Review
    • Relatively Speaking: COVID-19’s Impact on Cancer Screenings and Genetic Counseling Services.
    • Haidle JL.
    • Inside Precision Medicine. 2022 Aug 16 [2022 Aug];9(4).
    • Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants.
    • Edaily S, Abdel-Razeq H.
    • Onco Targets Ther. 2022 Jul 27;15:815-826. doi: 10.2147/OTT.S369844.
    • Editorial: Insight in cancer genetics: 2022.
    • Naro C, Cunliffe H, Sette C.
    • Front Oncol. 2022 Jul 26;12:988310. doi: 10.3389/fonc.2022.988310.
    • Cellular and molecular mechanisms of breast cancer susceptibility.
    • Shalabi SF, LaBarge MA.
    • Clin Sci (Lond). 2022 Jul 15;136(13):1025-1043. doi: 10.1042/CS20211158.
    • Review
    • Fertility Counseling in BRCA1/2-Mutated Women with Breast Cancer and Healthy Individuals.
    • Kufel-Grabowska J, Podolak A, Maliszewski D, Bartoszkiewicz M, Ramlau R, Lukaszuk K.
    • J Clin Med. 2022 Jul 10;11(14):3996. doi: 10.3390/jcm11143996.
    • Role of EMT in the DNA damage response, double-strand break repair pathway choice and its implications in cancer treatment.
    • Moyret-Lalle C, Prodhomme MK, Burlet D, Kashiwagi A, Petrilli V, Puisieux A, Seimiya H, Tissier A.
    • Cancer Sci. 2022 Jul;113(7):2214-2223. doi: 10.1111/cas.15389. Epub 2022 May 24.
    • Eighth International Symposium on hereditary breast and ovarian cancer : May 4-7, 2021 - Virtual Edition.
    • [No author given]
    • Fam Cancer. 2022 Jul;21(3):255-288. doi: 10.1007/s10689-021-00273-x.
    • Nine Myths About Men and Hereditary Cancer.
    • [No author given]
    • My Gene Counsel. Genetic Journal blog. 2022 Jun 15.
    • Not All Genetic Tests are Created Equal.
    • Cline M, Holdren J.
    • FORCE. Blog. 2022 Jun 14.
    • Common Multiple Primary Cancers Associated With Breast and Gynecologic Cancers and Their Risk Factors, Pathogenesis, Treatment and Prognosis: A Review.
    • Ge S, Wang B, Wang Z, He J, Ma X.
    • Front Oncol. 2022 Jun 8;12:840431. doi: 10.3389/fonc.2022.840431.
    • Editorial: Breast Cancer in Young Women: Dedicated Research Efforts Are Needed.
    • Lambertini M, Kim HJ, Poorvu P.
    • Front Oncol. 2022 Jun 1;12:913167. doi: 10.3389/fonc.2022.913167.
    • Cancer genetics and breast cancer.
    • Huber-Keener KJ.
    • Best Pract Res Clin Obstet Gynaecol. 2022 Jun;82:3-11. doi: 10.1016/j.bpobgyn.2022.01.007. Epub 2022 Jan 31.
    • Review
    • New approaches in ovarian cancer based on genetics and carcinogenesis hypotheses (Review).
    • Mogos RA, Popovici R, Tanase AE, Calistru T, Popovici P, Grigore M, Carauleanu A.
    • Exp Ther Med. 2022 Jun;23(6):423. doi: 10.3892/etm.2022.11351. Epub 2022 May 4.
    • Advocating for equitable management of hereditary cancer syndromes.
    • Caffrey RG.
    • J Genet Couns. 2022 Jun;31(3):584-589. doi: 10.1002/jgc4.1548. Epub 2022 Jan 14.
    • Commentary
    • Increased incidence of pathogenic variants in ATM in the context of testing for breast and ovarian cancer predisposition.
    • Macquere P, Orazio S, Bonnet F, Jones N, Bubien V, Chiron J, Lafon D, Barouk-Simonet E, Tinat J, Venat-Bouvet L, Gesta P, Longy M, Sevenet N.
    • J Hum Genet. 2022 Jun;67(6):339-345. doi: 10.1038/s10038-022-01014-3. Epub 2022 Jan 12.
    • Epidemiology and risk factors of ovarian cancer [Épidémiologie et facteurs de risque des cancers de l'ovaire].
    • Sanson C.
    • Rev Prat. 2022 Jun;72(6):618-620. French.
    • Genetic susceptibility to ovarian cancers [Oncogénétique dans les cancers de l'ovaire].
    • Desseignés C, R Benusiglio P.
    • Rev Prat. 2022 Jun;72(6):639-641. French.
    • Male Breast Cancer: An Updated Review of Epidemiology, Clinicopathology, and Treatment.
    • Zheng G, Leone JP.
    • J Oncol. 2022 May 24;2022:1734049. doi: 10.1155/2022/1734049.
    • Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature).
    • Smolarz B, Nowak AZ, Romanowicz H.
    • Cancers (Basel). 2022 May 23;14(10):2569. doi: 10.3390/cancers14102569.
    • Understanding the Experience of Canadian Women Living with Ovarian Cancer through the Every Woman Study™.
    • Tone A, Boghosian T, Ross A, Baugh E, Altman AD, Dawson L, Reid F, Crawford C.
    • Curr Oncol. 2022 May 5;29(5):3318-3340. doi: 10.3390/curroncol29050271.
    • Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
    • Lavoro A, Scalisi A, Candido S, Zanghì GN, Rizzo R, Gattuso G, Caruso G, Libra M, Falzone L.
    • Int J Oncol. 2022 May;60(5):58. doi: 10.3892/ijo.2022.5349. Epub 2022 Apr 6.
    • Hereditary gynecologic tumors and precision cancer medicine.
    • Ogawa C, Hirasawa A, Ida N, Nakamura K, Masuyama H.
    • J Obstet Gynaecol Res. 2022 May;48(5):1076-1090. doi: 10.1111/jog.15197. Epub 2022 Feb 28.
    • Review
    • Editorial: Familial Cancer in China: From Detection to Screening and Management.
    • Chen T, Yuan Y.
    • Front Oncol. 2022 Apr 29;12:916814. doi: 10.3389/fonc.2022.916814.
    • International LAGENO-BC Consortium Spurring Breast Cancer Genetics Research Across Latin America.
    • Hopkins C.
    • Precision Oncology News. Cancer Specialties. 2022 Apr 26.
    • News
    • Male Breast Cancer: From Molecular Genetics to Clinical Management.
    • Pensabene M, Von Arx C, De Laurentiis M.
    • Cancers (Basel). 2022 Apr 15;14(8):2006. doi: 10.3390/cancers14082006.
    • Not All Genetic Tests are Created Equal.
    • Cline M, Holdren J.
    • BRCA Exchange. 2022 Apr 14.
    • Partner Spotlight: Sharsheret.
    • Montoto R.
    • FORCE. Blog. 2022 Apr 8.
    • Hereditary Gynecologic Cancer Syndromes - A Narrative Review.
    • Kostov S, Watrowski R, Kornovski Y, Dzhenkov D, Slavchev S, Ivanova Y, Yordanov A.
    • Onco Targets Ther. 2022 Apr 8;15:381-405. doi: 10.2147/OTT.S353054.
    • Fallopian Tube Originating Ovarian Cancer in a 53-Year-Old Postmenopausal Female With Hereditary Breast Cancer (BRCA) Genes: A Case Study.
    • Garrick I, Ahasan H, Jiang M, Musheyev Y, Ftiha F, Levada M.
    • Cureus. 2022 Apr 7;14(4):e23929. doi: 10.7759/cureus.23929.
    • “You are BRCA2-Positive”: Studies that Have Helped Me.
    • Dreher ME.
    • FORCE. Blog. 2022 Apr 5.
    • Association of Genetic Ancestry and Molecular Signatures with Cancer Survival Disparities: A Pan-Cancer Analysis.
    • Lee KK, Rishishwar L, Ban D, Nagar SD, Mariño-Ramírez L, McDonald JF, Jordan IK.
    • Cancer Res. 2022 Apr 1;82(7):1222-1233. doi: 10.1158/0008-5472.CAN-21-2105.
    • Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors.
    • Schmutzler RK, Schmitz-Luhn B, Borisch B, Devilee P, Eccles D, Hall P, Balmaña J, Boccia S, Dabrock P, Emons G, Gaissmaier W, Gronwald J, Houwaart S, Huster S, Kast K, Katalinic A, Linn SC, Moorthie S, Pharoah P, Rhiem K, Spranger T, Stoppa-Lyonnet D, van Delden JJM, van den Bulcke M, Woopen C.
    • Breast Care (Basel). 2022 Apr;17(2):208-223. doi: 10.1159/000517182. Epub 2021 Aug 12.
    • Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients.
    • Meiser B, Woodward P, Gleeson M, Kentwell M, Fan HM, Antill Y, Butow PN, Boyle F, Best M, Taylor N, Bell K, Tucker K.
    • Fam Cancer. 2022 Apr;21(2):157-166. doi: 10.1007/s10689-021-00261-1. Epub 2021 May 10.
    • In AMIA Keynote, U of Chicago's Olopade Calls for More Diverse Data to Inform Precision Medicine.
    • Versel N.
    • Precision Oncology News. Biomarkers. BRCA. 2022 Mar 28.
    • Conference report
    • The Medical Side Effect We Must Stop Ignoring: Financial Toxicity.
    • Matloff E.
    • Forbes. 2022 Mar 11.

    Related:

    Commentary: Genetic Risks for Cancer Should Not Mean Financial Hardship. (The New York Times)

    • Breast cancer risk evaluation for the primary care physician.
    • Klassen CL, Gilman E, Kaur A, Lester SP, Pruthi S.
    • Cleve Clin J Med. 2022 Mar 1;89(3):139-146. doi: 10.3949/ccjm.89a.21023.
    • BRCA1 and Breast Cancer: Molecular Mechanisms and Therapeutic Strategies.
    • Fu X, Tan W, Song Q, Pei H, Li J.
    • Front Cell Dev Biol. 2022 Mar 1;10:813457. doi: 10.3389/fcell.2022.813457.
    • Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology.
    • Shah SM, Demidova EV, Lesh RW, Hall MJ, Daly MB, Meyer JE, Edelman MJ, Arora S.
    • Cancer Treat Rev. 2022 Mar;104:102337. doi: 10.1016/j.ctrv.2021.102337. Epub 2022 Jan 5.
    • BRCA mutations: Implications of genetic testing in ovarian cancer.
    • Talwar V, Rauthan A.
    • Indian J Cancer. 2022 Mar;59(Supplement):S56-S67. doi: 10.4103/ijc.IJC_1394_20.
    • Hereditary Breast and Ovarian Cancer: An Updated Primer for OB/GYNs.
    • Bellcross CA.
    • Obstet Gynecol Clin North Am. 2022 Mar;49(1):117-147. doi: 10.1016/j.ogc.2021.11.005.
    • Review
    • When breaks get hot: inflammatory signaling in BRCA1/2-mutant cancers.
    • van Vugt MATM, Parkes EE.
    • Trends Cancer. 2022 Mar;8(3):174-189. doi: 10.1016/j.trecan.2021.12.003. Epub 2022 Jan 6.
    • The BRCA Gene in Epithelial Ovarian Cancer.
    • Sánchez-Lorenzo L, Salas-Benito D, Villamayor J, Patiño-García A, González-Martín A.
    • Cancers (Basel). 2022 Feb 27;14(5):1235. doi: 10.3390/cancers14051235.
    • US Bill Seeks to Expand Access to Genetic Cancer Testing for Medicare Members.
    • [No author given]
    • Inside Precision Medicine. Topics. Oncology. 2022 Feb 23.
    • Senate Bill Proposes to Expand Medicare Coverage for Hereditary Cancer Testing.
    • [No author given]
    • GenomeWeb. Disease Areas. Cancer. 2022 Feb 17.
    • Improving the quality of care for patients with advanced epithelial ovarian cancer: Program components, implementation barriers, and recommendations.
    • Temkin SM, Smeltzer MP, Dawkins MD, Boehmer LM, Senter L, Black DR, Blank SV, Yemelyanova A, Magliocco AM, Finkel MA, Moore TE, Thaker PH.
    • Cancer. 2022 Feb 15;128(4):654-664. doi: 10.1002/cncr.34023. Epub 2021 Nov 17.
    • Human BRCA pathogenic variants were originated during recent human history.
    • Li J, Zhao B, Huang T, Qin Z, Wang SM.
    • Life Sci Alliance. 2022 Feb 14;5(5):e202101263. doi: 10.26508/lsa.202101263.
    • Chris Evert's ovarian cancer diagnosis highlights the importance of genetic counseling and testing.
    • [No author given]
    • FORCE. XRAY. 2022 Feb 8.

    Related:

    Press: Chris Evert opens up about her stage 1C ovarian cancer diagnosis. (ESPN)

    • BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer.
    • Petrucelli N, Daly MB, Pal T.
    • 1998 Sep 4 [updated 2022 Feb 3]. In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Mirzaa GM, Amemiya A, editors.
    • BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implications.
    • Petrova D, Cruz M, Sánchez MJ.
    • Breast. 2022 Feb;61:66-76. doi: 10.1016/j.breast.2021.12.005. Epub 2021 Dec 11.
    • An overview of genetic services delivery for hereditary breast cancer.
    • Reid S, Spalluto LB, Lang K, Weidner A, Pal T.
    • Breast Cancer Res Treat. 2022 Feb;191(3):491-500. doi: 10.1007/s10549-021-06478-z. Epub 2022 Jan 26.
    • 11 ESMO 2021 breakthroughs: practicing oncologist's perceptions on data presentation.
    • van Halteren HK, Tan A, Pellegrino B, Brasiuniene B, Bennouna J, Cunquero-Tomás AJ, Strijbos M; ESMO Practicing Oncologists Working Group.
    • ESMO Open. 2022 Feb;7(1):100376. doi: 10.1016/j.esmoop.2021.100376. Epub 2022 Jan 17.
    • Stakeholder attitudes towards establishing a national genomics registry of inherited cancer predisposition: a qualitative study.
    • Meiser B, Monnik M, Austin R, Nichols C, Cops E, Salmon L, Spurdle AB, Macrae F, Taylor N, Pachter N, James P, Kaur R.
    • J Community Genet. 2022 Feb;13(1):59-73. doi: 10.1007/s12687-021-00559-8. Epub 2021 Nov 2.
    • Population-Based Penetrance of Deleterious Clinical Variants.
    • Forrest IS, Chaudhary K, Vy HMT, Petrazzini BO, Bafna S, Jordan DM, Rocheleau G, Loos RJF, Nadkarni GN, Cho JH, Do R.
    • JAMA. 2022 Jan 25;327(4):350-359. doi: 10.1001/jama.2021.23686.

    Related:

    Press: Chance Most “Pathogenic” Variants Will Actually Cause Disease Is Low. (Inside Precision Medicine)

    Press: Pathogenic Variants in Disease-Causing Genes Have Low Penetrance on Average, Study Finds. (GenomeWeb)

    • Tennis Star Chris Evert Teaches Us That Genetic Testing Is A Lifetime Match.
    • Matloff E.
    • Forbes. Healthcare. 2022 Jan 17.

    Related:

    News: Tennis Star Chris Evert Teaches Us That Genetic Testing Is a Lifetime Match. (My Gene Counsel)

    • Chris Evert opens up about her stage 1C ovarian cancer diagnosis.
    • McKendry C, Evert C.
    • ESPN. 2022 Jan 14.

    Related:

    News: Chris Evert's ovarian cancer diagnosis highlights the importance of genetic counseling and testing. (FORCE. XRAY.)

    • Special Issue “Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer”.
    • Manchanda R.
    • Cancers (Basel). 2022 Jan 10;14(2):319. doi: 10.3390/cancers14020319.
    • Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients.
    • Tsaousis GN, Papadopoulou E, Agiannitopoulos K, Pepe G, Tsoulos N, Boukovinas I, Floros T, Iosifidou R, Katopodi O, Koumarianou A, Markopoulos C, Papazisis K, Venizelos V, Kapsimalis A, Xepapadakis G, Psyrri A, Banu E, Eniu DT, Blidaru A, Stanculeanu DL, Ungureanu A, Ozmen V, Tansan S, Tekinel M, Yalcin S, Nasioulas G.
    • Cancer Genomics Proteomics. 2022 Jan-Feb;19(1):60-78. doi: 10.21873/cgp.20304.
    • Identifying women with increased risk of breast cancer and implementing risk-reducing strategies and supplemental imaging.
    • Vegunta S, Bhatt AA, Choudhery SA, Pruthi S, Kaur AS.
    • Breast Cancer. 2022 Jan;29(1):19-29. doi: 10.1007/s12282-021-01298-x. Epub 2021 Oct 19.
    • Review
    • Current status of AYA-generation breast cancer: trends worldwide and in Japan.
    • Futamura M, Yoshida K.
    • Int J Clin Oncol. 2022 Jan;27(1):16-24. doi: 10.1007/s10147-021-02087-4. Epub 2021 Dec 18.
    • Review
    • Disparities in Genetic Testing for Heritable Solid-Tumor Malignancies.
    • Dillon J, Ademuyiwa FO, Barrett M, Moss HA, Wignall E, Menendez C, Hughes KS, Plichta JK.
    • Surg Oncol Clin N Am. 2022 Jan;31(1):109-126. doi: 10.1016/j.soc.2021.08.004. Epub 2021 Oct 19.
    • Review
    • [2. Paradigm Shift from the Experiences of Hereditary Breast Cancer].
    • Yamauchi H.
    • Nihon Hoshasen Gijutsu Gakkai Zasshi. 2022;78(5):531-534. Japanese. doi: 10.6009/jjrt.2022-2022.
    • [Article in Japanese]
    • DNA Damage Repair: Predictor of Platinum Efficacy in Ovarian Cancer?
    • Stefanou DT, Souliotis VL, Zakopoulou R, Liontos M, Bamias A.
    • Biomedicines. 2021 Dec 31;10(1):82. doi: 10.3390/biomedicines10010082.
    • Homologous Recombination Deficiencies and Hereditary Tumors.
    • Yamamoto H, Hirasawa A.
    • Int J Mol Sci. 2021 Dec 29;23(1):348. doi: 10.3390/ijms23010348.
    • A dangerous breast cancer gene mutation changed my life. As a health reporter, I want you to know about it. The PALB2 mutation is lesser-known than BRCA. It’s time to change that.
    • Berger S.
    • The Lily. (Washington Post). 2021 Dec 27.
    • Young Women with Breast Cancer in Resource-Limited Settings: What We Know and What We Need to Do Better.
    • Martinez-Cannon BA, Barragan-Carrillo R, Villarreal-Garza C.
    • Breast Cancer (Dove Med Press). 2021 Dec 2;13:641-650. doi: 10.2147/BCTT.S303047.
    • Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population.
    • Shen L, Zhang S, Wang K, Wang X.
    • Front Oncol. 2021 Dec 1;11:740227. doi: 10.3389/fonc.2021.740227.

    Related:

    Commentary:

    Editorial: Familial Cancer in China: From Detection to Screening and Management.

    • Guideline No. 422f: Menopause and Breast Cancer.
    • Jacobson M, Mills K, Graves G, Wolfman W, Fortier M.
    • J Obstet Gynaecol Can. 2021 Dec;43(12):1450-1456.e1. doi: 10.1016/j.jogc.2021.09.011. Epub 2021 Nov 17.
    • Guideline
    • Genetic Risks for Cancer Should Not Mean Financial Hardship.
    • Pierson L, Pierson E.
    • New York Times. Opinion. 2021 Nov 26.
    • Commentary

    Related:

    Commentary: The Medical Side Effect We Must Stop Ignoring: Financial Toxicity. (Forbes)

    • Genomic Instability and Cancer Risk Associated with Erroneous DNA Repair.
    • Yoshioka KI, Kusumoto-Matsuo R, Matsuno Y, Ishiai M.
    • Int J Mol Sci. 2021 Nov 12;22(22):12254. doi: 10.3390/ijms222212254.
    • A Review of Breast Cancer Risk Factors in Adolescents and Young Adults.
    • McVeigh UM, Tepper JW, McVeigh TP.
    • Cancers (Basel). 2021 Nov 5;13(21):5552. doi: 10.3390/cancers13215552.
    • HerediCaRe: Dokumentations- und IT-Lösung eines spezialisierten Registers für erblichen Brust- und Eierstockkrebs [HerediCaRe: Documentation and IT Solution of a Specialized Registry for Hereditary Breast and Ovarian Cancer].
    • Engel C, Wieland K, Zachariae S, Bucksch K, Enders U, Schoenwiese U, Yahiaoui-Doktor M, Keupp K, Waha A, Hahnen E, Remy R, Ernst C, Loeffler M, Schmutzler RK.
    • Gesundheitswesen. 2021 Nov;83(S 01):S12-S17. German. doi: 10.1055/a-1658-0313. Epub 2021 Nov 3.
    • MSK Fellows Develop Online Resource to Increase Awareness of Genetic Cascade Testing.
    • Kanski A.
    • Precision Oncology News. Technology. 2021 Oct 21.
    • News
    • Review: The Breast Cancer Book.
    • Steligo K.
    • FORCE. Blog. 2021 Oct 19.
    • Care of men with cancer-predisposing BRCA variants.
    • Horton R, Pharoah P, Hayward J, Lucassen A.
    • BMJ. 2021 Oct 14;375:n2376. doi: 10.1136/bmj.n2376.
    • Review
    • Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy.
    • Jiang M, Jia K, Wang L, Li W, Chen B, Liu Y, Wang H, Zhao S, He Y, Zhou C.
    • Acta Pharm Sin B. 2021 Oct;11(10):2983-2994. doi: 10.1016/j.apsb.2021.01.003. Epub 2021 Jan 6.
    • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.
    • Burstein HJ, Curigliano G, Thürlimann B, Weber WP, Poortmans P, Regan MM, Senn HJ, Winer EP, Gnant M; Panelists of the St Gallen Consensus Conference.
    • Ann Oncol. 2021 Oct;32(10):1216-1235. doi: 10.1016/j.annonc.2021.06.023. Epub 2021 Jul 6.
    • Genetic Technologies, WashU Team up to Study Breast Cancer Risk in Woman of African Descent.
    • [No author given]
    • Precision Oncology News. Diagnostics. 2021 Sep 28.
    • Male breast cancer: an update.
    • Fox S, Speirs V, Shaaban AM.
    • Virchows Arch. 2021 Aug 30. doi: 10.1007/s00428-021-03190-7. Epub ahead of print.
    • Review
    • Preventive population genomics: The model of BRCA related cancers.
    • Reisel D, Baran C, Manchanda R.
    • Adv Genet. 2021;108:1-33. doi: 10.1016/bs.adgen.2021.08.001. Epub 2021 Aug 26.
    • Review. Book chapter
    • Editorial: HBOC and high-risk screening: up-to-date.
    • Kataoka M.
    • Breast Cancer. 2021 Aug 23. doi: 10.1007/s12282-021-01284-3. Epub ahead of print.
    • The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data.
    • Gianni P, Matenoglou E, Geropoulos G, Agrawal N, Adnani H, Zafeiropoulos S, Miyara SJ, Guevara S, Mumford JM, Molmenti EP, Giannis D.
    • Clin Breast Cancer. 2021 Aug 10:S1526-8209(21)00238-X. doi: 10.1016/j.clbc.2021.08.001. Epub ahead of print.
    • Review
    • Guardians of the Genome: BRCA2 and Its Partners.
    • Le HP, Heyer WD, Liu J.
    • Genes (Basel). 2021 Aug 10;12(8):1229. doi: 10.3390/genes12081229.
    • Risks and Function of Breast Cancer Susceptibility Alleles.
    • Torabi Dalivandan S, Plummer J, Gayther SA.
    • Cancers (Basel). 2021 Aug 5;13(16):3953. doi: 10.3390/cancers13163953.
    • Update: Breast cancer disparities in Black Americans.
    • [No author given]
    • FORCE. XRAY. 2021 Aug 5.

    Related:

    Progress Report: Cancer Disparities Progress Report 2020: Achieving the Bold Vision of Health Equity for Racial and Ethnic Minorities and Other Underserved Populations. (AACR, American Association for Cancer Research)

    • Search Behavior Regarding Cancer Susceptibility Genes Using a Clinical Decision Support Tool for Gene-Specific Penetrance: Content Analysis.
    • Yin K, Zhou J, Singh P, Wang J, Braun D, Hughes KS.
    • JMIR Cancer. 2021 Jul 13;7(3):e28527. doi: 10.2196/28527.
    • Success Factors and Barriers in Combining Personalized Medicine and Patient Centered Care in Breast Cancer. Results from a Systematic Review and Proposal of Conceptual Framework.
    • de Belvis AG, Pellegrino R, Castagna C, Morsella A, Pastorino R, Boccia S.
    • J Pers Med. 2021 Jul 13;11(7):654. doi: 10.3390/jpm11070654.
    • Exploiting epigenetic dependencies in ovarian cancer therapy.
    • Coughlan AY, Testa G.
    • Int J Cancer. 2021 Jul 2. doi: 10.1002/ijc.33727. Epub ahead of print.
    • Review
    • Precision medicine in breast cancer: From clinical trials to clinical practice.
    • Crimini E, Repetto M, Aftimos P, Botticelli A, Marchetti P, Curigliano G.
    • Cancer Treat Rev. 2021 Jul;98:102223. doi: 10.1016/j.ctrv.2021.102223. Epub 2021 May 12.
    • Review
    • BRCA1/2 signaling and homologous recombination deficiency in breast and ovarian cancer.
    • Royfman R, Whiteley E, Noe O, Morand S, Creeden J, Stanbery L, Hamouda D, Nemunaitis J.
    • Future Oncol. 2021 Jul;17(21):2817-2830. doi: 10.2217/fon-2021-0072. Epub 2021 Jun 1.
    • Review
    • Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!
    • Abdel-Razeq H.
    • Oncol Rev. 2021 Jun 24;15(1):544. doi: 10.4081/oncol.2021.544.
    • One Woman’s Breast Cancer Journey: It’s Not Just About the Breast.
    • [No author given]
    • FORCE. Blog. 2021 Jun 21.

    Related:

    Information: It's Not (Just) About the Breast. (Well Strong Courage)

    • Ovarian Cancer: Biomarkers and Targeted Therapy.
    • Radu MR, Pradatu A, Duica F, Micu R, Cretoiu SM, Suciu N, Cretoiu D, Varlas VN, Radoi VE.
    • Biomedicines. 2021 Jun 18;9(6):693. doi: 10.3390/biomedicines9060693.
    • Disparity in Access to Oncology Precision Care: A Geospatial Analysis of Driving Distances to Genetic Counselors in the U.S.
    • Bellaiche MMJ, Fan W, Walbert HJ, McClave EH, Goodnight BL, Sieling FH, Moore RA, Meng W, Black CM.
    • Front Oncol. 2021 Jun 16;10:689927. doi: 10.3389/fonc.2021.689927.
    • Ashkenazi Dads Can Pass the BRCA Mutation to Their Kids. It Turns Out I Did.
    • Hertz B.
    • Kveller. 2021 Jun 14.

    Related:

    Blog post: Surviving, and Thriving, as a Dad with a Cancer Gene Mutation. (FORCE Blog)

    • A clinical case of diagnosis of breast cancer in patients with family history of BRCA mutations 1.
    • Aitmagambetova M, Smagulova G, Bekmukhambetov Y, Zavalyonnaya O, Tulyaeva A.
    • Rep Pract Oncol Radiother. 2021 Jun 9;26(3):463-469. doi: 10.5603/RPOR.a2021.0069.
    • The Functional Hallmarks of Cancer Predisposition Genes.
    • Capellini A, Williams M, Onel K, Huang KL.
    • Cancer Manag Res. 2021 Jun 1;13:4351-4357. doi: 10.2147/CMAR.S311548.
    • Gynecological lesions in hereditary cancer predisposition syndromes.
    • Dundr P, Cibula D, Foretová L, Macek M Jr, Kopecková K, Petruželka L, Nemejcová K, Bártu M, Hojný J, Hájková N, Jakša R, Janega P, Stružinská I.
    • Cesk Patol. 2021 Summer;57(2):96-104. English.
    • Quality and Quantity: How to Organize a Countrywide Genetic Counseling and Testing.
    • Schmutzler RK.
    • Breast Care (Basel). 2021 Jun;16(3):196-201. doi: 10.1159/000515429. Epub 2021 May 7.
    • From BRCA1 to Polygenic Risk Scores: Mutation-Associated Risks in Breast Cancer-Related Genes.
    • Woodward ER, van Veen EM, Evans DG.
    • Breast Care (Basel). 2021 Jun;16(3):202-213. doi: 10.1159/000515319. Epub 2021 Mar 31.
    • BRCA2: a 25-year journey from gene identification to targeted cancer treatment.
    • Grinda T, Delaloge S.
    • Lancet Oncol. 2021 Jun;22(6):763-764. doi: 10.1016/S1470-2045(21)00272-2.
    • Commentary
    • Familiärer Brust- und Eierstockkrebs: Auf was achten, was tun? [Hereditary breast and ovarian cancer. What to think about and what to do?].
    • Schönfeld M, Gassel K, Meister S, Amann N, Würstlein R, Mahner S, Harbeck N, Hester A.
    • MMW Fortschr Med. 2021 Jun;163(11):36-40. German. doi: 10.1007/s15006-021-9946-z.
    • Review. [Article in German]
    • Homologous recombination deficiency: cancer predispositions and treatment implications.
    • Toh MR, Ngeow J.
    • Oncologist. 2021 May 22. doi: 10.1002/onco.13829. Epub ahead of print.
    • Risk-Adjusted Prevention. Perspectives on the Governance of Entitlements to Benefits in the Case of Genetic (Breast Cancer) Risks.
    • Meier F, Harney A, Rhiem K, Neusser S, Neumann A, Braun M, Wasem J, Huster S, Dabrock P, Schmutzler RK.
    • Recent Results Cancer Res. 2021 [First Online: 22 May 2021];218:47-66. doi: 10.1007/978-3-030-63749-1_5.
    • eBook chapter
    • Next-Generation Sequencing-Based Biomarkers in Breast Cancer.
    • Han W, Lim W.
    • Adv Exp Med Biol. 2021 [First Online: 14 May 2021];1187:323-335. doi: 10.1007/978-981-32-9620-6_16.
    • Review, eBook chapter
    • BRCA and Breast Cancer-Related High-Penetrance Genes.
    • Han SA, Kim SW.
    • Adv Exp Med Biol. 2021 [First Online: 14 May 2021];1187:473-490. doi: 10.1007/978-981-32-9620-6_25.
    • Review, eBook chapter
    • Tracing ovarian cancer research in Morocco: A bibliometric analysis.
    • El Bairi K, Al Jarroudi O, Afqir S.
    • Gynecol Oncol Rep. 2021 May 7;37:100777. doi: 10.1016/j.gore.2021.100777.
    • One of the Biggest Healthcare Frauds Ever Is Still Ongoing — Cancer Genetic Testing Scams.
    • Mulcahy N.
    • Medscape Oncology. 2021 May 4.
    • Hérédité et cancer [Heredity and cancer].
    • Docampo E, Martin M, Gangolf M, Harvengt J, Bulk S, Segers K, Leroi N, Lete C, Palmariciotti V, Freire Chadrina V, Lambert F, Bours V.
    • Rev Med Liege. 2021 May;76(5-6):327-336. French.
    • Family Cancer Stories
    • Genetic Support Foundation.
    • YouTube. Genetic Support Foundation. 2021 Apr 24.

    Related:

    Resource: Genetic Support Foundation

    Blog post: Behind the Scenes of an Awareness Video: How a Genetic Support Foundation and BRCA Patients are Making a Difference. (FORCE Blog)

    • New advancements in cancer screenings bring hope for the future.
    • Meyer Krause C.
    • FORCE. Blog. 2021 Apr 23.

    Related:

    Research news: Update: FDA approves new imaging drug for detecting spread of prostate cancer. (FORCE. XRAY.)

    • Fast Five Quiz: Breast Cancer Myths.
    • Chalasani P.
    • Medscape. Drugs & Diseases. 2021 Apr 20.
    • Management of patients with BRCA mutation from the point of view of a breast surgeon.
    • Riis ML.
    • Ann Med Surg (Lond). 2021 Apr 16;65:102311. doi: 10.1016/j.amsu.2021.102311.
    • Current update on the molecular genetics and management of hereditary ovarian cancers: a primer for radiologists.
    • Itani M, Lalwani N, Ganeshan D, Zulfiqar M, Siegel C.
    • Abdom Radiol (NY). 2021 Apr 13. doi: 10.1007/s00261-020-02911-x. Epub ahead of print.
    • Review
    • Hunting for Hereditary Cancers.
    • May M.
    • Clinical OMICs. 2021 Apr 9. Mar/Apr 2021; 8(2).
    • Controversies in Hereditary Cancer Management.
    • AlHilli MM, Pederson HJ.
    • Obstet Gynecol. 2021 Apr 8. doi: 10.1097/AOG.0000000000004364. Epub ahead of print.
    • An overview on breast cancer genetics and recent innovations: Literature survey.
    • Ramya Sree PR, Thoppil JE.
    • Breast Dis. 2021 Apr 7. doi: 10.3233/BD-201040. Epub ahead of print.
    • Review
    • Clinical and Psychosocial Challenges of Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years.
    • Chaudhary LN.
    • JCO Oncol Pract. 2021 Apr 1:OP2100111. doi: 10.1200/OP.21.00111. Epub ahead of print.
    • Clinical and community genetics services in the Dutch Caribbean.
    • Verberne EA, Ecury-Goossen GM, Manshande ME, Ponson-Wever M, de Vroomen M, Tilanus M, Mannens MMAM, Henneman L, van Haelst MM.
    • J Community Genet. 2021 Mar 10:1-5. doi: 10.1007/s12687-021-00515-6. Epub ahead of print.

    Related:

    Duplicate:

    Clinical and community genetics services in the Dutch Caribbean.

    • The Importance of Learning Your Pancreatic Cancer Risk When Cancer Runs in Your Family.
    • Coffin T.
    • FORCE. Blog. 2021 Mar 2.
    • [Involvement of Variants in the Genes Encoding BRCA1-Associated Genome Surveillance Complex (BASC) in the Development of Human Common Diseases].
    • Babushkina NP, Postrigan AE, Kucher AN.
    • Mol Biol (Mosk). 2021 Mar-Apr;55(2):318-337. Russian. doi: 10.31857/S0026898421020038.
    • Review, [Article in Russian]
    • Gene Screenings Hold Disease Clues, but Unexplained Anomalies Often Raise Fears.
    • Bennett C.
    • KHN [Kaiser Health News]. 2021 Feb 9.

    Related:

    Press: Ambiguous genetic test results can be unsettling. Worse, they can lead to needless surgeries. (Washington Post)

    Press: My Gene Counsel Quoted in Washington Post and Kaiser Health News. (My Gene Counsel)

    • Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine.
    • Horgan D, Ciliberto G, Conte P, Curigliano G, Seijo L, Montuenga LM, Garassino M, Penault-Llorca F, Galli F, Ray-Coquard I, Querleu D, Riegman P, Kerr K, Van Poppel H, Bjartell A, Codacci-Pisanelli G, Koeva-Balabanova J, Paradiso A, Maravic Z, Fotaki V, Malats N, Bernini C, Buglioni S, Kent A, Munzone E, Belina I, Van Meerbeeck J, Duffy M, Jagielska B, Capoluongo E.
    • Cancers (Basel). 2021 Feb 2;13(3):583. doi: 10.3390/cancers13030583.
    • Estimation of healthcare-related charges in women with BRCA mutations and breast cancer.
    • Biskupiak J, Unni S, Telford C, Yoo M, Ye X, Deka R, Brixner D, Stenehjem D.
    • BMC Health Serv Res. 2021 Jan 13;21(1):58. doi: 10.1186/s12913-020-06038-z.
    • Honoring the Life of Teri Woodhull.
    • [No author given]
    • FORCE. Blog. 2021 Jan 13.
    • Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes-Practice resource of the National Society of Genetic Counselors.
    • Berliner JL, Cummings SA, Boldt Burnett B, Ricker CN.
    • J Genet Couns. 2021 Jan 7. doi: 10.1002/jgc4.1374. Epub ahead of print.
    • Guidelines
    • Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    • Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML; CGC, Karlan BY, Khan S, Klein C, Kohlmann W; CGC, Kurian AW, Laronga C, Litton JK, Mak JS; LCGC, Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G; CGC, Senter-Jamieson L; CGC, Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA.
    • J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001.
    • Why is appropriate healthcare inaccessible for many European breast cancer patients? - The EBCC 12 manifesto.
    • Cardoso F, MacNeill F, Penault-Llorca F, Eniu A, Sardanelli F, Nordström EB, Poortmans P.
    • Breast. 2021 Jan 2;55:128-135. doi: 10.1016/j.breast.2020.12.010. Epub ahead of print.
    • Triple-Negative Breast Cancer: Breast Tumors With an Identity Crisis.
    • Nunnery SE, Mayer IA, Balko JM.
    • Cancer J. 2021 Jan-Feb 01;27(1):2-7. doi: 10.1097/PPO.0000000000000494.
    • Review
    • Epidemiology of Triple-Negative Breast Cancer: A Review.
    • Howard FM, Olopade OI.
    • Cancer J. 2021 Jan-Feb 01;27(1):8-16. doi: 10.1097/PPO.0000000000000500.
    • Review
    • Fast Five Quiz: How Much Do You Know About the Genetics of Breast Cancer?
    • Markman M.
    • Medscape. Drugs & Diseases. 2020 Dec 29.
    • My Gene Counsel, Genomet Develop Decision Support Solution for Precision Cancer Care.
    • [No author given]
    • Precision Oncology News. 2020 Dec 29.
    • Molecular Features and Clinical Management of Hereditary Gynecological Cancers.
    • Ueki A, Hirasawa A.
    • Int J Mol Sci. 2020 Dec 14;21(24):E9504. doi: 10.3390/ijms21249504.
    • BRCA testing delay during the COVID-19 pandemic: How to act?
    • Minucci A, Scambia G, De Bonis M, De Paolis E, Santonocito C, Fagotti A, Capoluongo E, Concolino P, Urbani A.
    • Mol Biol Rep. 2020 Dec 12. doi: 10.1007/s11033-020-06060-8. Epub ahead of print.
    • Non-invasive Technology Advances in Cancer-A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers.
    • Openshaw MR, McVeigh TP.
    • Front Digit Health. 2020 Dec 11;2:573010. doi: 10.3389/fdgth.2020.573010.
    • Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987-2020).
    • Howell A, Gandhi A, Howell S, Wilson M, Maxwell A, Astley S, Harvie M, Pegington M, Barr L, Baildam A, Harkness E, Hopwood P, Wisely J, Wilding A, Greenhalgh R, Affen J, Maurice A, Cole S, Wiseman J, Lalloo F, French DP, Evans DG.
    • Cancers (Basel). 2020 Dec 9;12(12):3697. doi: 10.3390/cancers12123697.
    • Editorial: Hereditary Breast and Ovarian Cancer: Current Concepts of Prevention and Treatment.
    • Grabenstetter A, Lazaro C, Turashvili G.
    • Front Oncol. 2020 Dec 2;10:618369. doi: 10.3389/fonc.2020.618369.
    • Genetics and the Gynecologic Patient.
    • Wade KS, Estes JM, Kline RC.
    • Ochsner J. 2020 Winter;20(4):446-451. doi: 10.31486/toj.20.0051.
    • Alterations of DNA damage repair in cancer: from mechanisms to applications.
    • Jiang M, Jia K, Wang L, Li W, Chen B, Liu Y, Wang H, Zhao S, He Y, Zhou C.
    • Ann Transl Med. 2020 Dec;8(24):1685. doi: 10.21037/atm-20-2920.
    • Current practices on genetic testing in ovarian cancer.
    • Fostira F, Papadimitriou M, Papadimitriou C.
    • Ann Transl Med. 2020 Dec;8(24):1703. doi: 10.21037/atm-20-1422.
    • A review of inherited cancer susceptibility syndromes.
    • Brown GR, Simon M, Wentling C, Spencer DM, Parker AN, Rogers CA.
    • JAAPA. 2020 Dec;33(12):10-16. doi: 10.1097/01.JAA.0000721648.46099.2c.
    • Clinically Actionable Findings Derived From Predictive Genomic Testing Offered in a Medical Practice Setting.
    • Anderson JL, Kruisselbrink TM, Lisi EC, Hughes TM, Steyermark JM, Winkler EM, Berg CM, Vierkant RA, Gupta R, Ali AH, Faubion SS, Aoudia SL, McAllister TM, Farrugia G, Stewart AK, Lazaridis KN.
    • Mayo Clin Proc. 2020 Oct 21:S0025-6196(20)31119-8. doi: 10.1016/j.mayocp.2020.08.051. Epub ahead of print.
    • Celebrities Share Their Breast Cancer Stories.
    • [No author given]
    • My Gene Counsel. Genetic Journal. 2020 Oct 7.
    • Advances in epithelial ovarian cancer.
    • Neesham D, Richards A, McGauran M.
    • Aust J Gen Pract. 2020 Oct;49(10):665-669.
    • Was ist neu bei der Diagnostik und Therapie des Mammakarzinoms? – Aktuelle Standards in der Behandlung von Brustkrebs [Breast cancer - state of the art - Short overview of the current standard of treatment].
    • Albert A, Stüber T, Bauer J, Wöckel A.
    • Dtsch Med Wochenschr. 2020 Oct;145(20):1460-1463. German. doi: 10.1055/a-1026-3620. Epub 2020 Oct 6.
    • Review, [Article in German]
    • Bioethics and healthcare policies. The benefit of using genetic tests of BRCA 1 and BRCA 2 in elderly patients.
    • Fonseca V, Caeiro J.
    • Int J Health Plann Manage. 2020 Sep 25. doi: 10.1002/hpm.3072. Epub ahead of print.
    • Commentary
    • Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.
    • Green RF, Kumerow MT, Rodriguez JL, Addie S, Beachy SH, Senier L.
    • Public Health Genomics. 2020 Sep 17:1-12. doi: 10.1159/000510336. Epub ahead of print.

    Related:

    Original research:

    Proposed outcomes measures for state public health genomic programs.

    • Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes.
    • Pietragalla A, Arcieri M, Marchetti C, Scambia G, Fagotti A.
    • Int J Gynecol Cancer. 2020 Sep 6:ijgc-2020-001556. doi: 10.1136/ijgc-2020-001556. Epub ahead of print.
    • Review
    • Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis.
    • Yoshida R.
    • Breast Cancer. 2020 Aug 29. doi: 10.1007/s12282-020-01148-2. Epub ahead of print.
    • An overview of cancer genetics with focus on involvement of BRCA1/2 genes in breast carcinomas.
    • Tahir DE, Rehman MS, Rehman MU.
    • J Pak Med Assoc. 2020 Jul;70(7):1240-1247. doi: 10.5455/JPMA.20351.
    • DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome.
    • Tomasova K, Cumova A, Seborova K, Horak J, Koucka K, Vodickova L, Vaclavikova R, Vodicka P.
    • Cancers (Basel). 2020 Jun 28;12(7):E1713. doi: 10.3390/cancers12071713.
    • Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives.
    • Cocco S, Piezzo M, Calabrese A, Cianniello D, Caputo R, Lauro VD, Fusco G, Gioia GD, Licenziato M, Laurentiis M.
    • Int J Mol Sci. 2020 Jun 27;21(13):E4579. doi: 10.3390/ijms21134579.
    • Managing a woman with BRCA mutations? Shared decision-making is key.
    • Schrager S, Torell E, Ledford K, Elezaby M, Barroleit L, Sadowski E.
    • J Fam Pract. 2020 Jun;69(5):237-243.
    • Executive Summary of the Early-Onset Breast Cancer Evidence Review Conference.
    • Chelmow D, Pearlman MD, Young A, Bozzuto L, Dayaratna S, Jeudy M, Kremer ME, Scott DM, O'Hara JS.
    • Obstet Gynecol. 2020 Jun;135(6):1457-1478. doi: 10.1097/AOG.0000000000003889.
    • Cancer Genetics.
    • Van Cott C.
    • Surg Clin North Am. 2020 Jun;100(3):483-498. doi: 10.1016/j.suc.2020.02.012. Epub 2020 Apr 16.
    • Review
    • A systematic literature review of whole exome and genome sequencing population studies of genetic susceptibility to cancer.
    • Rotunno M, Barajas R, Clyne M, Hoover E, Simonds NI, Lam TK, Mechanic LE, Goldstein AM, Gillanders E.
    • Cancer Epidemiol Biomarkers Prev. 2020 May 28:cebp.1551.2019. doi: 10.1158/1055-9965.EPI-19-1551. Epub ahead of print.
    • Cancer du sein chez la femme jeune: considérations particulières et implications pour la pratique [Breast cancer in young women: implications for clinical practice].
    • Seidler S, Huber D.
    • Rev Med Suisse. 2020 May 27;16(695):1106-1113. French.
    • Review, [Article in French]
    • Updates in hereditary breast cancer genetic testing and practical high risk breast management in gene carriers.
    • Pederson HJ, Noss R.
    • Semin Oncol. 2020 May 26:S0093-7754(20)30047-6. doi: 10.1053/j.seminoncol.2020.05.008. Epub ahead of print.
    • Review
    • Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options.
    • Francies FZ, Hull R, Khanyile R, Dlamini Z.
    • Am J Cancer Res. 2020 May 1;10(5):1568-1591.
    • Integrating Genetic and Genomic Testing Into Oncology Practice.
    • Domchek SM, Mardis E, Carlisle JW, Owonikoko TK.
    • Am Soc Clin Oncol Educ Book. 2020 May;40:e259-e263. doi: 10.1200/EDBK_280607.
    • National Minority Cancer Awareness Month: Is the Cancer in Your Family Hereditary?
    • Wu J.
    • FORCE Blog. 2020 Apr 22.
    • Blog post

    Related:

    Blog post: Luck Is More Than Just A Rainbow: A Previvor’s Story. (FORCE Blog)

    • Prevalence of clinically actionable disease variants in exceptionally long-lived families.
    • Carlson P, Wojczynski MK, Druley T, Lee JH, Zmuda JM, Thyagarajan B.
    • BMC Med Genomics. 2020 Apr 10;13(1):61. doi: 10.1186/s12920-020-0710-5.
    • Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets.
    • Fang CB, Wu HT, Zhang ML, Liu J, Zhang GJ.
    • Front Cell Dev Biol. 2020 Apr 2;8:160. doi: 10.3389/fcell.2020.00160. eCollection 2020.
    • Young Women With Breast Cancer: Treatment, Care, and Nursing Implications.
    • Corey B, Smania MA, Spotts H, Andersen M.
    • Clin J Oncol Nurs. 2020 Apr 1;24(2):139-147. doi: 10.1188/20.CJON.139-147.
    • Review
    • Fast Five Quiz: How Much Do You Know About the Genetics of Breast Cancer?
    • Markman M.
    • Medscape. 2020 Apr 1.
    • Current Indications for Consideration of Evaluation for Hereditary Cancer Predisposition Syndromes and How They Can Change Management.
    • Massingham LJ, De Souza A.
    • R I Med J (2013). 2020 Apr 1;103(3):20-24.
    • Review
    • [Hereditary breast carcinomas pathologist's perspective].
    • Vincent-Salomon A, Bataillon G, Djerroudi L.
    • Ann Pathol. 2020 Mar 30. pii: S0242-6498(20)30059-6. doi: 10.1016/j.annpat.2020.02.023. [Epub ahead of print]
    • Review, [Article in French]
    • Molecular Trajectory of BRCA1 and BRCA2 Mutations.
    • Hatano Y, Tamada M, Matsuo M, Hara A.
    • Front Oncol. 2020 Mar 25;10:361. doi: 10.3389/fonc.2020.00361. eCollection 2020.
    • Genetics/Familial Risk Assessment for Breast Cancer: Controversies and Evolving Principles.
    • Weitzel JN.
    • National Comprehensive Cancer Network. Continuing Education. 2020 Mar 15.
    • DNA tests grow more vital in hereditary breast cancer treatments. They also raise unanswerable questions.
    • Richards SE.
    • Washington Post. Health & Science. 2020 Mar 15.
    • Feasibility, patient compliance and acceptability of ovarian cancer surveillance using two serum biomarkers and Risk of Ovarian Cancer Algorithm compared to standard ultrasound and CA 125 among women with BRCA mutations.
    • Haque R, Skates SJ, Armstrong MA, Lentz SE, Anderson M, Jiang W, Alvarado MM, Chillemi G, Shaw SF, Kushi LH, Powell CB.
    • Gynecol Oncol. 2020 Mar 4. pii: S0090-8258(20)30164-5. doi: 10.1016/j.ygyno.2020.02.027. [Epub ahead of print]
    • BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies.
    • Lee A, Moon BI, Kim TH.
    • Ann Lab Med. 2020 Mar;40(2):114-121. doi: 10.3343/alm.2020.40.2.114.
    • Review

    Related:

    Introductory article:

    From Genetic Testing to Treatment and Prevention of BRCA-Related Breast Cancer.

    • Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil.
    • Achatz MI, Caleffi M, Guindalini R, Marques RM, Nogueira-Rodrigues A, Ashton-Prolla P.
    • JCO Glob Oncol. 2020 Mar;6:439-452. doi: 10.1200/JGO.19.00170.
    • [Hereditary breast and ovarian cancer syndrome: Diagnosis and therapeutic implications].
    • Koual M, Perkins G, Delanoy N, Crespel C, Medioni J, Nguyen-Xuan HT, Douay-Hauser N, Blons H, Le Frère-Belda MA, Molière D, Achen G, Nos C, Balaya V, Montero R, Laurent-Puig P, Bats AS.
    • Ann Pathol. 2020 Feb 8. pii: S0242-6498(20)30026-2. doi: 10.1016/j.annpat.2020.01.004. [Epub ahead of print]
    • Review, [Article in French]
    • Breast cancer suspected to originate from familial hereditary tumors: A case report.
    • Yamamoto S, Chishima T, Sugae S, Shibata Y, Yamada A.
    • Clin Case Rep. 2020 Feb 8;8(4):648-652. doi: 10.1002/ccr3.2698. eCollection 2020 Apr.
    • Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
    • Angeli D, Salvi S, Tedaldi G.
    • Int J Mol Sci. 2020 Feb 8;21(3). pii: E1128. doi: 10.3390/ijms21031128.
    • Gene signatures of breast cancer development and the potential for novel targeted treatments.
    • Kothari C, Diorio C, Durocher F.
    • Pharmacogenomics. 2020 Feb;21(3):157-161. doi: 10.2217/pgs-2019-0158.
    • Current Approaches to Germline Cancer Genetic Testing.
    • Stoffel EM, Carethers JM.
    • Annu Rev Med. 2020 Jan 27;71:85-102. doi: 10.1146/annurev-med-052318-101009. Epub 2019 Nov 22.
    • Review
    • Genetic testing for epithelial ovarian cancer.
    • Amin N, Chaabouni N, George A.
    • Best Pract Res Clin Obstet Gynaecol. 2020 Jan 16. pii: S1521-6934(20)30017-1. doi: 10.1016/j.bpobgyn.2020.01.005. [Epub ahead of print]
    • [Advances in Oncology 2019].
    • Vernadou A, Ferahta N, Mederos N, Ferraro D, Dischl-Antonioni I, Diciolla A, Liapi A, Mosimann V, Latifyan S, Aedo-Lopez V, Berthold D, Digklia A, Michielin O, Montemurro M, Wagner AD, Zaman K, Peters S1, Stravodimou A, Sarivalasis A.
    • Rev Med Suisse. 2020 Jan 15;16(676-7):72-77.
    • Review, Article in French
    • Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening.
    • Offit K, Tkachuk KA, Stadler ZK, Walsh MF, Diaz-Zabala H, Levin JD, Steinsnyder Z, Ravichandran V, Sharaf RN, Frey MK, Lipkin SM, Robson ME, Hamilton JG, Vijai J, Mukherjee S.
    • J Clin Oncol. 2020 Jan 10:JCO1902010. doi: 10.1200/JCO.19.02010. [Epub ahead of print]
    • SEOM clinical guidelines in hereditary breast and ovarian cancer (2019).
    • González-Santiago S, Ramón Y Cajal T, Aguirre E, Alés-Martínez JE, Andrés R, Balmaña J, Graña B, Herrero A, Llort G, González-Del-Alba A; SEOM Hereditary Cancer Working Group.
    • Clin Transl Oncol. 2019 Dec 30. doi: 10.1007/s12094-019-02262-0. [Epub ahead of print]
    • A Genetic Test Led Seven Women in One Family to Have Major Surgery. Then the Odds Changed.
    • Marcus AD.
    • The Wall Street Journal. 2019 Dec 20.
    • Press

    Related:

    Press: Downgraded Variant. (GenomeWeb)

    • Genetic Protection Modifications: Moving Beyond the Binary Distinction Between Therapy and Enhancement for Human Genome Editing.
    • Mikkelsen RB, Frederiksen HRS, Gjerris M, Holst B, Hyttel P, Luo Y, Freude K, Sandøe P.
    • CRISPR J. 2019 Dec;2(6):362-369. doi: 10.1089/crispr.2019.0024.
    • Commentary
    • Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.
    • [No authors listed]
    • Obstet Gynecol. 2019 Dec;134(6):e143-e149. doi: 10.1097/AOG.0000000000003562.

    Related:

    Summary:

    Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.

    • The OncoLifeS data-biobank for oncology: a comprehensive repository of clinical data, biological samples, and the patient's perspective.
    • Sidorenkov G, Nagel J, Meijer C, Duker JJ, Groen HJM, Halmos GB, Oonk MHM, Oostergo RJ, van der Vegt B, Witjes MJH, Nijland M, Havenga K, Maduro JH, Gietema JA, de Bock GH.
    • J Transl Med. 2019 Nov 14;17(1):374. doi: 10.1186/s12967-019-2122-x.
    • Hereditary prostate cancer - Primetime for genetic testing?
    • Heidegger I, Tsaur I, Borgmann H, Surcel C, Kretschmer A, Mathieu R, Visschere P, Valerio M, van den Bergh RCN, Ost P, Tilki D, Gandaglia G, Ploussard G; EAU-YAU Prostate Cancer Working Party.
    • Cancer Treat Rev. 2019 Nov 11;81:101927. doi: 10.1016/j.ctrv.2019.101927. [Epub ahead of print]
    • Review
    • [What attitude to women at high risk of breast cancer?]
    • Livon D, Moretta J, Noguès C.
    • Presse Med. 2019 Nov 6. pii: S0755-4982(19)30302-1. doi: 10.1016/j.lpm.2019.07.014. [Epub ahead of print]
    • Review, [Article in French]
    • Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer.
    • [No author given]
    • National Institute for Health and Care Excellence (UK): Clinical Guidelines; 2013 Jun. [Last Update: November 2019.]
    • New Consumer Podcast Highlights Steps Individuals Can Take to Understand Cancer Risk.
    • [No author given]
    • NSGC blog, 2019 Oct 29.

    Related:

    Podcast: Genetic Counselors and You — Breast Cancer Awareness Month. (NSGC "Genetic Counselors & You" Podcast Series)

    • Genetic and Genomic Advances in Breast Cancer Diagnosis and Treatment.
    • Walker-Smith TL, Peck J.
    • Nurs Womens Health. 2019 Oct 25. pii: S1751-4851(19)30188-6. doi: 10.1016/j.nwh.2019.09.003. [Epub ahead of print]
    • Review
    • Cases in Precision Medicine: The Role of Tumor and Germline Genetic Testing in Breast Cancer Management.
    • Tischler J, Crew KD, Chung WK.
    • Ann Intern Med. 2019 Oct 22. doi: 10.7326/M18-2417. [Epub ahead of print]
    • Review
    • Ellen Matloff's Forbes Article: What Beyoncé's Dad and Angelina Jolie Have in Common.
    • Matloff E.
    • My Gene Counsel. 2019 Oct 21.
    • Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy.
    • Urbina-Jara LK, Rojas-Martinez A, Martinez-Ledesma E, Aguilar D, Villarreal-Garza C, Ortiz-Lopez R.
    • Genes (Basel). 2019 Oct 10;10(10). pii: E786. doi: 10.3390/genes10100786.
    • Beyoncé's Dad Just Revealed His Breast Cancer Diagnosis—Here's What You Need to Know About Male Breast Cancer.
    • Brenza A.
    • Health. 2019 Oct 3.
    • Luck Is More Than Just A Rainbow: A Previvor’s Story.
    • @PALB2Previvor
    • FORCE Blog. 2019 Oct 2.
    • Cancer Genetic Counseling—Current Practice and Future Challenges.
    • Schienda J, Stopfer J.
    • Cold Spring Harb Perspect Med. 2019 Sep 23. pii: a036541. doi: 10.1101/cshperspect.a036541. [Epub ahead of print]
    • Review
    • Breast cancer.
    • Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J, Cardoso F.
    • Nat Rev Dis Primers. 2019 Sep 23;5(1):66. doi: 10.1038/s41572-019-0111-2.
    • Review
    • Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
    • Batalini F, Peacock EG, Stobie L, Robertson A, Garber J, Weitzel JN, Tung NM.
    • Breast Cancer Res. 2019 Sep 18;21(1):107. doi: 10.1186/s13058-019-1193-1.
    • Breast Cancer Screening in BRCA Mutation Carriers: Necessity of a Relevant Update of Mammographic Modalities.
    • Colin C, Doutriaux-Dumoulin I.
    • Radiology. 2019 Sep 3:191306. doi: 10.1148/radiol.2019191306. [Epub ahead of print]
    • Letter, Comment

    Related:

    Original research:

    BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations.

    • Cancer: more genetic BRCA testing for men.
    • Marabelli M, Calvello M, Bonanni B.
    • Nature. 2019 Sep;573(7774):346. doi: 10.1038/d41586-019-02775-2.

    Related:

    Commentary:

    New name for breast-cancer syndrome could help to save lives.

    • DNA Damage and Hormone Related Cancer: a repair pathway view.
    • Pooley KA, Dunning AM.
    • Hum Mol Genet. 2019 Aug 22. pii: ddz206. doi: 10.1093/hmg/ddz206. [Epub ahead of print]
    • Review
    • Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions.
    • Simeonidis S, Koutsilieri S, Vozikis A, Cooper DN, Mitropoulou C, Patrinos GP.
    • Front Pharmacol. 2019 Aug 2;10:830. doi: 10.3389/fphar.2019.00830. eCollection 2019.
    • The role of BRCA1/2 in hereditary and familial breast and ovarian cancers.
    • Hawsawi YM, Al-Numair NS, Sobahy TM, Al-Ajmi AM, Al-Harbi RM, Baghdadi MA, Oyouni AA, Alamer OM.
    • Mol Genet Genomic Med. 2019 Jul 17:e879. doi: 10.1002/mgg3.879. [Epub ahead of print]
    • Practical Cancer Genetics and Genomics in Women's Health.
    • Modesitt S, Pederson HJ, Adkins RT.
    • Clin Obstet Gynecol. 2019 Jul 11. doi: 10.1097/GRF.0000000000000480. [Epub ahead of print]
    • Review
    • How do mutations affecting the breast cancer genes BRCA1 and BRCA2 cause cancer susceptibility?
    • Venkitaraman AR.
    • DNA Repair (Amst). 2019 Jul 8:102668. doi: 10.1016/j.dnarep.2019.102668. [Epub ahead of print]
    • Review
    • [Hereditary Breast and Ovarian Cancer Syndrome].
    • Inuzuka M, Nakamura S.
    • Gan To Kagaku Ryoho. 2019 Jul;46(7):1109-1113.
    • Review, [Article in Japanese]
    • Lessons learned from two decades of BRCA1 and BRCA2 genetic testing: the evolution of data sharing and variant classification.
    • Toland AE, Brody LC; BIC Steering Committee.
    • Genet Med. 2019 Jul;21(7):1476-1480. doi: 10.1038/s41436-018-0370-4. Epub 2018 Nov 26.
    • Review
    • New name for breast-cancer syndrome could help to save lives.
    • Pritchard CC.
    • Nature. 2019 Jul;571(7763):27-29. doi: 10.1038/d41586-019-02015-7.

    Related:

    Letter:

    Cancer: more genetic BRCA testing for men.

    Press: New Name of 'King Syndrome' for Hereditary BRCA Mutations. (Medscape Oncology)

    • Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference.
    • Bast RC Jr, Matulonis UA, Sood AK, Ahmed AA, Amobi AE, Balkwill FR, Wielgos-Bonvallet M, Bowtell DDL, Brenton JD, Brugge JS, Coleman RL, Draetta GF, Doberstein K, Drapkin RI, Eckert MA, Edwards RP, Elias KM, Ennis D, Futreal A, Gershenson DM, Greenberg RA, Huntsman DG, Ji JXY, Kohn EC, Iavarone C, Lengyel ER, Levine DA, Lord CJ1, Lu Z, Mills GB, Modugno F, Nelson BH, Odunsi K, Pilsworth JA, Rottapel RK, Powell DJ Jr, Shen L, Shih IM, Spriggs DR, Walton J, Zhang K, Zhang R, Zou L.
    • Cancer. 2019 Jun 15;125(12):1963-1972. doi: 10.1002/cncr.32004. Epub 2019 Mar 5.
    • Conference report, Commentary
    • A young woman's story of genetic testing and risk-reducing mastectomy.
    • [No author given]
    • FORCE. XRAYS. 2019 Jun 6.

    Related:

    Narrative: I Had a Preventive Mastectomy—Then Found Out I Already Had Breast Cancer. (Health)

    • [Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer.]
    • Foretová L, Navrátilová M, Svoboda M, Vašíčková P, Sťahlová EH, Házová J, Kleiblová P, Kleibl Z, Macháčková E, Palácová M, Petráková K.
    • Klin Onkol. 2019 Summer;32(Supplementum2):6-13. doi: 10.14735/amko2019S6.
    • Cancer Genomics for Oncologists: Cancer Risk and Management of BRCA1 and BRCA2 Carriers.
    • George A.
    • Curr Genet Med Rep. 2019 Jun;7(2):116-123. doi: 10.1007/s40142-019-00167-6. Epub 2019 May 9.
    • Review
    • Hereditary Cancer Syndromes-A Primer on Diagnosis and Management: Part 1: Breast-Ovarian Cancer Syndromes.
    • Samadder NJ, Giridhar KV, Baffy N, Riegert-Johnson D, Couch FJ.
    • Mayo Clin Proc. 2019 Jun;94(6):1084-1098. doi: 10.1016/j.mayocp.2019.02.017.
    • [Epidemiology and diagnosis of breast cancer].
    • Budny A, Starosławska E, Budny B, Wójcik R, Hys M, Kozłowski P, Budny W, Brodzik A, Burdan F.
    • Pol Merkur Lekarski. 2019 May 27;46(275):195-204.
    • Review, [Article in Polish]
    • Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.
    • Gori S, Barberis M, Bella MA, Buttitta F, Capoluongo E, Carrera P, Colombo N, Cortesi L, Genuardi M, Gion M, Guarneri V, Incorvaia L, La Verde N, Lorusso D, Marchetti A, Marchetti P, Normanno N, Pasini B, Pensabene M, Pignata S, Radice P, Ricevuto E, Sapino A, Tagliaferri P, Tassone P, Trevisiol C, Truini M, Varesco L, Russo A; AIOM-SIGU-SIBIOC-SIAPEC-IAP Working Group.
    • Crit Rev Oncol Hematol. 2019 May 25;140:67-72. doi: 10.1016/j.critrevonc.2019.05.012. [Epub ahead of print]
    • Epithelial ovarian cancer: Evolution of management in the era of precision medicine.
    • Lheureux S, Braunstein M, Oza AM.
    • CA Cancer J Clin. 2019 May 17. doi: 10.3322/caac.21559. [Epub ahead of print]
    • Epithelial ovarian cancer risk: a review of the current genetic landscape.
    • Flaum N, Crosbie EJ, Edmondson RJ, Smith MJ, Evans DG.
    • Clin Genet. 2019 May 16. doi: 10.1111/cge.13566. [Epub ahead of print]
    • Review
    • Insights Into Breast Cancer in the East vs the West: A Review.
    • Yap YS, Lu YS, Tamura K, Lee JE, Ko EY, Park YH, Cao AY, Lin CH, Toi M, Wu J, Lee SC.
    • JAMA Oncol. 2019 May 16. doi: 10.1001/jamaoncol.2019.0620. [Epub ahead of print]
    • Review
    • BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance.
    • Gorodetska I, Kozeretska I, Dubrovska A.
    • J Cancer. 2019 May 14;10(9):2109-2127. doi: 10.7150/jca.30410. eCollection 2019.
    • Unraveling a difficult diagnosis: the tricks for early recognition of ovarian cancer.
    • Giampaolino P, Della Corte L, Foreste V, Vitale SG, Chiofalo B, Cianci S, Zullo F, Bifulco G.
    • Minerva Med. 2019 May 6. doi: 10.23736/S0026-4806.19.06086-5. [Epub ahead of print]
    • Review
    • Hereditary ovarian cancers: state of the art.
    • Toss A, Molinaro E, Sammarini M, Del Savio MC, Cortesi L, Facchinetti F, Grandi G.
    • Minerva Med. 2019 May 6. doi: 10.23736/S0026-4806.19.06091-9. [Epub ahead of print]
    • Review
    • Germline and Somatic Mutations in Prostate Cancer for the Clinician.
    • Cheng HH, Sokolova AO, Schaeffer EM, Small EJ, Higano CS.
    • J Natl Compr Canc Netw. 2019 May 1;17(5):515-521. doi: 10.6004/jnccn.2019.7307.
    • Whole genome sequencing of breast cancer.
    • Rossing M, Sørensen CS, Ejlertsen B, Nielsen FC.
    • APMIS. 2019 May;127(5):303-315. doi: 10.1111/apm.12920. Epub 2019 Jan 28.
    • Hereditary breast cancer; Genetic penetrance and current status with BRCA.
    • Mahdavi M, Nassiri M, Kooshyar MM, Vakili-Azghandi M, Avan A, Sandry R, Pillai S, Lam AK, Gopalan V.
    • J Cell Physiol. 2019 May;234(5):5741-5750. doi: 10.1002/jcp.27464. Epub 2018 Dec 14.
    • Review
    • Global Disparities in Breast Cancer Genetics Testing, Counselling and Management.
    • Yip CH, Evans DG, Agarwal G, Buccimazza I, Kwong A, Morant R, Prakash I, Song CY, Taib NA, Tausch C, Ung O, Meterissian S.
    • World J Surg. 2019 May;43(5):1264-1270. doi: 10.1007/s00268-018-04897-6.
    • BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations.
    • Elezaby M, Lees B, Maturen KE, Barroilhet L, Wisinski KB, Schrager S, Wilke LG, Sadowski E.
    • Radiology. 2019 Apr 30:181814. doi: 10.1148/radiol.2019181814. [Epub ahead of print]

    Related:

    Letter, Comment:

    Breast Cancer Screening in BRCA Mutation Carriers: Necessity of a Relevant Update of Mammographic Modalities.

    • Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era.
    • Macedo GS, Alemar B, Ashton-Prolla P.
    • Genet Mol Biol. 2019 Apr 29. pii: S1415-47572019005015101. doi: 10.1590/1678-4685-GMB-2018-0104. [Epub ahead of print]
    • Scientific supremacy as an obstacle to establishing and sustaining interdisciplinary dialogue across knowledge paradigms in health medicine.
    • Gripsrud BH, Solbrække KN.
    • Med Health Care Philos. 2019 Apr 25. doi: 10.1007/s11019-019-09901-x. [Epub ahead of print]

    Related:

    Commentary:

    Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.

    Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.

    • BRCA1-No Matter How You Splice It.
    • Li D, Harlan-Williams LM, Kumaraswamy E, Jensen RA.
    • Cancer Res. 2019 Apr 16. doi: 10.1158/0008-5472.CAN-18-3190. [Epub ahead of print]
    • Review
    • Epidemiological characteristics of and risk factors for breast cancer in the world.
    • Momenimovahed Z, Salehiniya H.
    • Breast Cancer (Dove Med Press). 2019 Apr 10;11:151-164. doi: 10.2147/BCTT.S176070. eCollection 2019.
    • Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report.
    • Spurdle AB, Greville-Heygate S, Antoniou AC, Brown M, Burke L, de la Hoya M, Domchek S, Dörk T, Firth HV, Monteiro AN, Mensenkamp A, Parsons MT, Radice P, Robson M, Tischkowitz M, Tudini E, Turnbull C, Vreeswijk MP, Walker LC, Tavtigian S, Eccles DM.
    • J Med Genet. 2019 Apr 8. pii: jmedgenet-2018-105872. doi: 10.1136/jmedgenet-2018-105872. [Epub ahead of print]
    • Review, Guidelines
    • Identifying a BRCA2 c.5722_5723del mutation in a Han-Chinese family with breast cancer.
    • Guo Y, Wang P, Li X, Zhu S, Xu H, Li S, Deng H, Yuan L.
    • Biosci Rep. 2019 Apr 2. pii: BSR20182471. doi: 10.1042/BSR20182471. [Epub ahead of print]
    • Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes.
    • Vos JR, Giepmans L, Röhl C, Geverink N, Hoogerbrugge N; ERN GENTURIS.
    • Fam Cancer. 2019 Apr;18(2):281-284. doi: 10.1007/s10689-018-0110-6.
    • Current Approaches to Cancer Genetic Counseling Services for Spanish-Speaking Patients.
    • Augusto B, Kasting ML, Couch FJ, Lindor NM, Vadaparampil ST.
    • J Immigr Minor Health. 2019 Apr;21(2):434-437. doi: 10.1007/s10903-018-0772-z.
    • Ovarian Cancer: An Integrated Review.
    • Stewart C, Ralyea C, Lockwood S.
    • Semin Oncol Nurs. 2019 Apr;35(2):151-156. doi: 10.1016/j.soncn.2019.02.001. Epub 2019 Mar 11.
    • Review
    • The BRCA Tumor Suppressor Network in Chromosome Damage Repair by Homologous Recombination.
    • Zhao W, Wiese C, Kwon Y, Hromas R, Sung P.
    • Annu Rev Biochem. 2019 Mar 27. doi: 10.1146/annurev-biochem-013118-111058. [Epub ahead of print]
    • Review
    • Breast surgeons recommend genetic testing for all breast cancer patients.
    • [No author given]
    • FORCE. XRAYS. 2019 Mar 25.

    Related:

    Guideline: Consensus Guideline on Genetic Testing for Hereditary Breast Cancer. (PDF) (American Society of Breast Surgeons.)

    • Epithelial ovarian cancer.
    • Lheureux S, Gourley C, Vergote I, Oza AM.
    • Lancet. 2019 Mar 23;393(10177):1240-1253. doi: 10.1016/S0140-6736(18)32552-2.
    • Review
    • Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer.
    • Willoughby A, Andreassen PR, Toland AE.
    • J Pers Med. 2019 Mar 1;9(1). pii: E15. doi: 10.3390/jpm9010015.
    • Hereditary cancer syndromes, their testing and prevention.
    • Foretová L.
    • Cas Lek Cesk. 2019 Spring;158(1):15-21.
    • Review
    • The Fanconi Anemia Pathway in Cancer.
    • Niraj J, Färkkilä A, D'Andrea AD.
    • Annu Rev Cancer Biol. 2019 Mar;3:457-478. doi: 10.1146/annurev-cancerbio-030617-050422. Epub 2018 Dec 3.
    • BRCA Exchange Launches.
    • [No authors listed]
    • Cancer Discov. 2019 Mar;9(3):311-312. doi: 10.1158/2159-8290.CD-NB2019-008. Epub 2019 Jan 24.
    • News
    • Author response to "a response to 'personalised medicine and population health: breast and ovarian cancer'".
    • Narod SA.
    • Hum Genet. 2019 Mar;138(3):291-292. doi: 10.1007/s00439-019-01981-2. Epub 2019 Feb 21.
    • Letter, Reply

    Related:

    Letter, Commentary:

    A response to "Personalised medicine and population health: breast and ovarian cancer".

    Review:

    Personalised medicine and population health: breast and ovarian cancer.

    • Breast Cancer Screening: Why Can't Everyone Agree?
    • Jordan V, Khan M, Prill D.
    • Prim Care. 2019 Mar;46(1):97-115. doi: 10.1016/j.pop.2018.10.010. Epub 2018 Dec 22.
    • Review
    • Leveraging Implementation Science to Address Health Disparities in Genomic Medicine: Examples from the Field.
    • Roberts MC, Mensah GA, Khoury MJ.
    • Ethn Dis. 2019 Feb 21;29(Suppl 1):187-192. doi: 10.18865/ed.29.S1.187. eCollection 2019.
    • Women's cancers: how the discovery of BRCA genes is driving current concepts of cancer biology and therapeutics.
    • Murthy P, Muggia F.
    • Ecancermedicalscience. 2019 Feb 14;13:904. doi: 10.3332/ecancer.2019.904. eCollection 2019.
    • Consensus Guideline on Genetic Testing for Hereditary Breast Cancer.
    • Manahan ER, Sebastian M, Hughes KS, Boughey JC, Kuerer HM, Euhus DM, Robson ME, Boolbol SK, Arun BK, Taylor WA.
    • American Society of Breast Surgeons. 2019 Feb 10.

    Related:

    Press: ASBrS Calls for Genetic Testing for All Breast Cancer Patients. (Medscape Oncology)

    News: Breast surgeons recommend genetic testing for all breast cancer patients. (FORCE. XRAYS.)

    • The cost of cancer care and impact of financial hardship on treatment.
    • [No author given]
    • FORCE. XRAYS. 2019 Feb 8.

    Related:

    Original research:

    BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer.

    News: Labs, Advocacy Groups Push Back on Medicare Policy Shift on NGS Testing for Hereditary Cancer Risk. (GenomeWeb)

    News: Pricey Precision Medicine Often Financially Toxic For Cancer Patients. (Kaiser Health News)

    • Genetic Service Delivery Models: Exploring Approaches to Care for Families With Hereditary Cancer Risk.
    • Pierle JM, Mahon SM.
    • Clin J Oncol Nurs. 2019 Feb 1;23(1):60-67. doi: 10.1188/19.CJON.60-67.
    • Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer.
    • Wendt C, Margolin S.
    • Acta Oncol. 2019 Feb;58(2):135-146. doi: 10.1080/0284186X.2018.1529428. Epub 2019 Jan 3.
    • [Hereditary predisposition to breast cancer (1): genetics].
    • Cohen-Haguenauer O.
    • Med Sci (Paris). 2019 Feb;35(2):138-151. doi: 10.1051/medsci/2019003. Epub 2019 Feb 18.
    • Guidelines-Based Cancer Risk Assessment.
    • Forman A, Schwartz S.
    • Semin Oncol Nurs. 2019 Feb;35(1):34-46. doi: 10.1016/j.soncn.2018.12.010. Epub 2019 Jan 22.
    • Hereditary Breast and Hereditary Ovarian Cancer: Implications for the Oncology Nurse.
    • Beamer LC.
    • Semin Oncol Nurs. 2019 Feb;35(1):47-57. doi: 10.1016/j.soncn.2018.12.001. Epub 2019 Jan 30.
    • Shared heritability and functional enrichment across six solid cancers.
    • Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, Aldrich MC, Andrew AS, Andrulis IL, Anton-Culver H, Antoniou AC, Antonenkova NN, Arnold SM, Aronson KJ, Arun BK, Bandera EV, Barkardottir RB, Barnes DR, Batra J, Beckmann MW, Benitez J, Benlloch S, Berchuck A, Berndt SI, Bickeböller H, Bien SA, Blomqvist C, Boccia S, Bogdanova NV, Bojesen SE, Bolla MK, Brauch H, Brenner H, Brenton JD, Brook MN, Brunet J, Brunnström H, Buchanan DD, Burwinkel B, Butzow R, Cadoni G, Caldés T, Caligo MA, Campbell I, Campbell PT, Cancel-Tassin G, Cannon-Albright L, Campa D, Caporaso N, Carvalho AL, Chan AT, Chang-Claude J, Chanock SJ, Chen C, Christiani DC, Claes KBM, Claessens F, Clements J, Collée JM, Correa MC, Couch FJ, Cox A, Cunningham JM, Cybulski C, Czene K, Daly MB, deFazio A, Devilee P, Diez O, Gago-Dominguez M, Donovan JL, Dörk T, Duell EJ, Dunning AM, Dwek M, Eccles DM, Edlund CK, Edwards DRV, Ellberg C, Evans DG, Fasching PA, Ferris RL, Liloglou T, Figueiredo JC, Fletcher O, Fortner RT, Fostira F, Franceschi S, Friedman E, Gallinger SJ, Ganz PA, Garber J, García-Sáenz JA, Gayther SA, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, Goode EL, Goodman MT, Goodman G, Grankvist K, Greene MH, Gronberg H, Gronwald J, Guénel P, Håkansson N, Hall P, Hamann U, Hamdy FC, Hamilton RJ, Hampe J, Haugen A, Heitz F, Herrero R, Hillemanns P, Hoffmeister M, Høgdall E, Hong YC, Hopper JL, Houlston R, Hulick PJ, Hunter DJ, Huntsman DG, Idos G, Imyanitov EN, Ingles SA, Isaacs C, Jakubowska A, James P, Jenkins MA, Johansson M, Johansson M, John EM, Joshi AD, Kaneva R, Karlan BY, Kelemen LE, Kühl T, Khaw KT, Khusnutdinova E, Kibel AS, Kiemeney LA, Kim J, Kjaer SK, Knight JA, Kogevinas M, Kote-Jarai Z, Koutros S, Kristensen VN, Kupryjanczyk J, Lacko M, Lam S, Lambrechts D, Landi MT, Lazarus P, Le ND, Lee E, Lejbkowicz F, Lenz HJ, Leslie G, Lessel D, Lester J, Levine DA, Li L, Li CI, Lindblom A, Lindor NM, Liu G, Loupakis F, Lubiński J, Maehle L, Maier C, Mannermaa A, Marchand LL, Margolin S, May T, McGuffog L, Meindl A, Middha P, Miller A, Milne RL, MacInnis RJ, Modugno F, Montagna M, Moreno V, Moysich KB, Mucci L, Muir K, Mulligan AM, Nathanson KL, Neal DE, Ness AR, Neuhausen SL, Nevanlinna H, Newcomb PA, Newcomb LF, Nielsen FC, Nikitina-Zake L, Nordestgaard BG, Nussbaum RL, Offit K, Olah E, Olama AAA, Olopade OI, Olshan AF, Olsson H, Osorio A, Pandha H, Park JY, Pashayan N, Parsons MT, Pejovic T, Penney KL, Peters WHM, Phelan CM, Phipps AI, Plaseska-Karanfilska D, Pring M, Prokofyeva D, Radice P, Stefansson K, Ramus SJ, Raskin L, Rennert G, Rennert HS, van Rensburg EJ, Riggan MJ, Risch HA, Risch A, Roobol MJ, Rosenstein BS, Rossing MA, De Ruyck K, Saloustros E, Sandler DP, Sawyer EJ, Schabath MB, Schleutker J, Schmidt MK, Setiawan VW, Shen H, Siegel EM, Sieh W, Singer CF, Slattery ML, Sorensen KD, Southey MC, Spurdle AB, Stanford JL, Stevens VL, Stintzing S, Stone J, Sundfeldt K, Sutphen R, Swerdlow AJ, Tajara EH, Tangen CM, Tardon A, Taylor JA, Teare MD, Teixeira MR, Terry MB, Terry KL, Thibodeau SN, Thomassen M, Bjørge L, Tischkowitz M, Toland AE, Torres D, Townsend PA, Travis RC, Tung N, Tworoger SS, Ulrich CM, Usmani N, Vachon CM, Van Nieuwenhuysen E, Vega A, Aguado-Barrera ME, Wang Q, Webb PM, Weinberg CR, Weinstein S, Weissler MC, Weitzel JN, West CML, White E, Whittemore AS, Wichmann HE, Wiklund F, Winqvist R, Wolk A, Woll P, Woods M, Wu AH, Wu X, Yannoukakos D, Zheng W, Zienolddiny S, Ziogas A, Zorn KK, Lane JM, Saxena R, Thomas D, Hung RJ, Diergaarde B, McKay J, Peters U, Hsu L, García-Closas M, Eeles RA, Chenevix-Trench G, Brennan PJ, Haiman CA, Simard J, Easton DF, Gruber SB, Pharoah PDP, Price AL, Pasaniuc B, Amos CI, Kraft P, Lindström S.
    • Nat Commun. 2019 Jan 25;10(1):431. doi: 10.1038/s41467-018-08054-4.
    • Triple-negative breast cancer: the reality in Chile and in Latin America.
    • Caglevic C, Anabalón J, Soza C, Milla E, Gaete F, Carrasco AM, Panay S, Gallardo C, Mahave M.
    • Ecancermedicalscience. 2019 Jan 22;13:893. doi: 10.3332/ecancer.2019.893. eCollection 2019.
    • BRCA1 and Breast Cancer: a Review of the Underlying Mechanisms Resulting in the Tissue-Specific Tumorigenesis in Mutation Carriers.
    • Semmler L, Reiter-Brennan C, Klein A.
    • J Breast Cancer. 2019 Jan 22;22(1):1-14. doi: 10.4048/jbc.2019.22.e6. eCollection 2019 Mar.
    • Germline Genetic Testing for Breast Cancer Risk: The Past, Present, and Future.
    • Yadav S, Couch FJ.
    • Am Soc Clin Oncol Educ Book. 2019 Jan;(39):61-74. doi: 10.1200/EDBK_238987.
    • Molecular Testing in Breast Cancer.
    • Litton JK, Burstein HJ, Turner NC.
    • Am Soc Clin Oncol Educ Book. 2019 Jan;(39):e1-e7. doi: 10.1200/EDBK_237715.
    • BRCA mutations: is everything said?
    • López-Urrutia E, Salazar-Rojas V, Brito-Elías L, Coca-González M, Silva-García J, Sánchez-Marín D, Campos-Parra AD, Pérez-Plasencia C.
    • Breast Cancer Res Treat. 2019 Jan;173(1):49-54. doi: 10.1007/s10549-018-4986-5. Epub 2018 Oct 6.
    • Review
    • Challenges in the identification of inherited risk of ovarian cancer: where should we go from here?
    • Norquist BM.
    • Gynecol Oncol. 2019 Jan;152(1):3-6. doi: 10.1016/j.ygyno.2018.12.003. Epub 2018 Dec 8.
    • Epidemiology of Breast Cancer in Women.
    • Coughlin SS.
    • Adv Exp Med Biol. 2019;1152:9-29. doi: 10.1007/978-3-030-20301-6_2.
    • Review
    • Health and Racial Disparity in Breast Cancer.
    • Yedjou CG, Sims JN, Miele L, Noubissi F, Lowe L, Fonseca DD, Alo RA, Payton M, Tchounwou PB.
    • Adv Exp Med Biol. 2019;1152:31-49. doi: 10.1007/978-3-030-20301-6_3.
    • Review
    • Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    • Franceschini G, Di Leone A, Terribile D, Sanchez MA, Masetti R.
    • Ann Ital Chir. 2019;90:1-2.
    • Review
    • A new look at molecular biology of breast cancer.
    • Ma C, Nepal M, Kim JH, Fan P, Fei P.
    • Cancer Biol Ther. 2019;20(1):1-5. doi: 10.1080/15384047.2018.1507259. Epub 2018 Sep 6.
    • BRCA Mutations and Breast Cancer Prevention.
    • Kotsopoulos J.
    • Cancers (Basel). 2018 Dec 19;10(12). pii: E524. doi: 10.3390/cancers10120524.
    • BRCA1-Dependent Transcriptional Regulation: Implication in Tissue-Specific Tumor Suppression.
    • Zhang X, Li R.
    • Cancers (Basel). 2018 Dec 14;10(12). pii: E513. doi: 10.3390/cancers10120513.
    • Gynecological-endocrinological aspects in women carriers of BRCA1/2 gene mutations.
    • Doren A, Vecchiola A, Aguirre B, Villaseca P.
    • Climacteric. 2018 Dec;21(6):529-535. doi: 10.1080/13697137.2018.1514006. Epub 2018 Oct 8.
    • Review
    • [III. Hereditary Breast and/or Ovarian Cancer Syndrome].
    • Sugitani I.
    • Gan To Kagaku Ryoho. 2018 Dec;45(12):1720-1724.
    • Review, [Article in Japanese]
    • Breast cancer in adolescents and young adults.
    • Johnson RH, Anders CK, Litton JK, Ruddy KJ, Bleyer A.
    • Pediatr Blood Cancer. 2018 Dec;65(12):e27397. doi: 10.1002/pbc.27397. Epub 2018 Aug 28.
    • Review
    • Big Data Sharing: A Crucial Democratic Issue for Genomic Medicine.
    • Derbez B.
    • Front Public Health. 2018 Nov 28;6:334. doi: 10.3389/fpubh.2018.00334. eCollection 2018.
    • Cancer genetics program: Follow-up on clinical genetics and genomic medicine in Qatar.
    • Al-Bader SB, Alsulaiman R, Bugrein H, Ben Omran T, Abbaszadeh F, Bakheet N, Apsa Kusasi S, Abdou N, Solomon BD, Ghazouani H.
    • Mol Genet Genomic Med. 2018 Nov;6(6):865-872. doi: 10.1002/mgg3.534. Epub 2018 Dec 16.
    • Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition.
    • Jatoi I.
    • Eur J Breast Health. 2018 Oct 1;14(4):189-193. doi: 10.5152/ejbh.2018.4324. eCollection 2018 Oct.

    Related:

    Letter, Review:

    What The Surgeons Should Know About The Bilateral Prophylactic Mastectomy in BRCA Mutation Carriers.

    • New Breast Cancer Screening Guidelines Build on Progress.
    • Larsen Haidle J.
    • NSGC blog, 2018 Oct 1.

    Related:

    Guidelines: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) — Genetic/Familial High-Risk Assessment: Breast and Ovarian (PDF) (NCCN.org)

    • Germline and somatic genetic testing in ovarian cancer patients.
    • Chandrasekaran D, Manchanda R.
    • BJOG. 2018 Oct;125(11):1460. doi: 10.1111/1471-0528.15225. Epub 2018 May 10.
    • Commentary
    • Personalised medicine and population health: breast and ovarian cancer.
    • Narod SA.
    • Hum Genet. 2018 Oct;137(10):769-778. doi: 10.1007/s00439-018-1944-6. Epub 2018 Oct 17.
    • Review

    Related:

    Letter, Commentary:

    A response to "Personalised medicine and population health: breast and ovarian cancer".

    Letter, Reply:

    Author response to “a response to ‘personalised medicine and population health: breast and ovarian cancer’”.

    • Changing landscape of hereditary breast and ovarian cancer germline genetic testing in Australia.
    • Petelin L, James PA, Trainer AH.
    • Intern Med J. 2018 Oct;48(10):1269-1272. doi: 10.1111/imj.14058.
    • Commentary, Review
    • My Father’s Fight Against the Breast-Cancer Gene.
    • Munster P.
    • The Wall Street Journal. The Saturday Essay. 2018 Sep 28.

    Related:

    Blog post: Pamela Munster's story: Cancer in the family (FORCE. XRAYS.)

    • Twisting Fate. My Journey with BRCA—from Breast Cancer Doctor to Patient and Back
    • Pamela Munster
    • The Experiment (publisher). 2018 Sep 25. ISBN 978-1-61519-478-0. 272 pages. Hardcover, Ebook.
    • Book

    Related:

    Essay: My Father’s Fight Against the Breast-Cancer Gene. (The Wall Street Journal.)

    • Cancer experience in families affects decision making.
    • [No author given]
    • FORCE. XRAYS. 2018 Sep 25.

    Related:

    Press: How a Loved One’s Experience With Cancer Guides Breast Cancer Decisions. (U.S. News & World Report)

    • How are genetic test results being used by Australian life insurers?
    • Barlow-Stewart K, Liepins M, Doble A, Otlowski M.
    • Eur J Hum Genet. 2018 Sep;26(9):1248-1256. doi: 10.1038/s41431-018-0198-z. Epub 2018 Jun 11.
    • Proposed outcomes measures for state public health genomic programs.
    • Doyle DL, Clyne M, Rodriguez JL, Cragun DL, Senier L, Hurst G, Chan K, Chambers DA.
    • Genet Med. 2018 Sep;20(9):995-1003. doi: 10.1038/gim.2017.229. Epub 2018 Jan 4.

    Related:

    Original research:

    Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.

    • Sporadic and Hereditary Breast Cancer Genetics.
    • Zehr KR.
    • Radiol Technol. 2018 Sep;90(1):51M-64M.
    • Review
    • Breast Cancer Genetics and Indications for Prophylactic Mastectomy.
    • Krontiras H, Farmer M, Whatley J.
    • Surg Clin North Am. 2018 Aug;98(4):677-685. doi: 10.1016/j.suc.2018.03.004. Epub 2018 May 30.
    • Review
    • NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) — Genetic/Familial High-Risk Assessment: Breast and Ovarian
    • Daly MB, Pilarski R, Berry M, Buys SS, Friedman S, Garber JE, Hutton ML, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Laronga C, Litton JK, Madlensky L, Mac JS, Merajver SD, Offit K, Pal T, Peterson HJ, Reiser G, Shannon KM, Thaker P, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Darlow S.
    • NCCN.org. 2018 Jul 11. Version 1.2019.
    • BRCA genes: BRCA 1 and BRCA 2.
    • Varol U, Kucukzeybek Y, Alacacioglu A, Somali I, Altun Z, Aktas S, Oktay Tarhan M.
    • J BUON. 2018 Jul-Aug;23(4):862-866.
    • Clinical Cancer Genetics in a Lower-Middle Income Country: Considerations for Policymaking.
    • Ginsburg O, Narod SA.
    • J Glob Oncol. 2018 Jul;(4):1-3. doi: 10.1200/JGO.18.00081.

    Related:

    Knowledge of Genetic Counseling Among Patients With Breast Cancer and Their Relatives at a Nigerian Teaching Hospital.

    • First international TNBC conference meeting report.
    • Rida P, Ogden A, Ellis IO, Varga Z, Wolff AC, Traina TA, Hatzis C, Palmer JR, Ambrosone CB, Lehmann BD, Nanda R, Montgomery Rice V, Brawley OW, Torres MA, Rakha E, Aneja R.
    • Breast Cancer Res Treat. 2018 Jun;169(3):407-412. doi: 10.1007/s10549-018-4692-3. Epub 2018 Feb 8.
    • Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.
    • Møller P, Hovig E.
    • Med Health Care Philos. 2018 Jun;21(2):239-242. doi: 10.1007/s11019-017-9803-0.

    Related:

    Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.

    Commentary, Reply:

    Scientific supremacy as an obstacle to establishing and sustaining interdisciplinary dialogue across knowledge paradigms in health medicine.

    • BRCA Mutations in the Young, High-Risk Female Population: Genetic Testing, Management of Prophylactic Therapies, and Implications for Plastic Surgeons.
    • Salibian AA, Frey JD, Choi M, Karp NS.
    • Plast Reconstr Surg. 2018 Jun;141(6):1341-1350. doi: 10.1097/PRS.0000000000004363.
    • Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis.
    • Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, Ji X, Liu W, Huang B, Luo W, Liu B, Lei Y, Du S, Vuppalapati A, Luu HH, Haydon RC, He TC, Ren G.
    • Genes Dis. 2018 May 12;5(2):77-106. doi: 10.1016/j.gendis.2018.05.001. eCollection 2018 Jun.
    • 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts.
    • Untch M, Würstlein R, Marschner N, Lüftner D, Augustin D, Briest S, Ettl J, Haidinger R, Müller L, Müller V, Ruckhäberle E, Harbeck N, Thomssen C.
    • Geburtshilfe Frauenheilkd. 2018 May;78(5):469-480. doi: 10.1055/a-0594-2243. Epub 2018 Jun 4.
    • Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.
    • Wunderle M, Olmes G, Nabieva N, Häberle L, Jud SM, Hein A, Rauh C, Hack CC, Erber R, Ekici AB, Hoyer J, Vasileiou G, Kraus C, Reis A, Hartmann A, Schulz-Wendtland R, Lux MP, Beckmann MW, Fasching PA.
    • Geburtshilfe Frauenheilkd. 2018 May;78(5):481-492. doi: 10.1055/a-0603-4350. Epub 2018 Jun 4.
    • Not quite healthy, not quite sick, women at risk of hereditary cancer can 'fall through the medical cracks'.
    • Karlamangla S.
    • Los Angeles Times, Health & Wellness, 2018 Apr 8.
    • PALB2 (partner and localizer of BRCA2).
    • Hanenberg H, Andreassen PR.
    • Atlas Genet Cytogenet Oncol Haematol. 2018 Apr;22(12):484-490. doi: 10.4267/2042/69016.
    • BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far.
    • Sharma B, Preet Kaur R, Raut S, Munshi A.
    • Curr Probl Cancer. 2018 Mar - Apr;42(2):189-207. doi: 10.1016/j.currproblcancer.2018.01.001. Epub 2018 Jan 8.
    • Review
    • Hereditary Breast and Ovarian Cancer Syndrome: Moving Beyond BRCA1 and BRCA2.
    • Hoang LN, Gilks BC.
    • Adv Anat Pathol. 2018 Mar;25(2):85-95. doi: 10.1097/PAP.0000000000000177.
    • Review
    • Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer.
    • Chen CC, Feng W, Lim PX, Kass EM, Jasin M.
    • Annu Rev Cancer Biol. 2018 Mar;2:313-336. doi: 10.1146/annurev-cancerbio-030617-050502. Epub 2017 Dec 1.
    • Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
    • Oaknin A, Guarch R, Barretina P, Hardisson D, González A, Matías-Guiu X, Pérez-Fidalgo A, Vieites B, Romero I, Palacios J.
    • Clin Transl Oncol. 2018 Mar;20(3):274-285. doi: 10.1007/s12094-017-1719-x. Epub 2017 Aug 16.
    • Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention.
    • Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Kolberg HC, Hadji P, Tesch H, Wöckel A, Ettl J, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wallwiener D, Brucker SY, Schütz F, Fasching PA, Fehm TN.
    • Geburtshilfe Frauenheilkd. 2018 Mar;78(3):246-259. doi: 10.1055/s-0044-101614. Epub 2018 Mar 21.
    • Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk Reduction.
    • Ring KL, Modesitt SC.
    • Obstet Gynecol Clin North Am. 2018 Mar;45(1):155-173. doi: 10.1016/j.ogc.2017.10.011.
    • Review
    • Hereditary breast cancer: molecular biology and management update.
    • Yamashita H.
    • Int J Clin Oncol. 2018 Feb;23(1):35. doi: 10.1007/s10147-017-1183-1. Epub 2017 Aug 24.
    • BRCA1 gene: function and deficiency.
    • Takaoka M, Miki Y.
    • Int J Clin Oncol. 2018 Feb;23(1):36-44. doi: 10.1007/s10147-017-1182-2. Epub 2017 Sep 7.
    • Review
    • Gynaecological neoplasms in common familial syndromes (Lynch and HBOC).
    • Bartosch C, Clarke B, Bosse T.
    • Pathology. 2018 Feb;50(2):222-237. doi: 10.1016/j.pathol.2017.10.010. Epub 2017 Dec 26.
    • Review
    • A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors.
    • Shailani A, Kaur RP, Munshi A.
    • Med Oncol. 2018 Jan 31;35(3):18. doi: 10.1007/s12032-018-1085-8.
    • Review
    • Your Genes: One Size Doesn't Fit All.
    • Freivogel ME, Cohen SA.
    • J Natl Compr Canc Netw. 2018 Jan 1;16(1):2-3. doi: 10.6004/jnccn.2017.7055.
    • Commentary

    Related:

    Commentary:

    Your Genes: Getting the Best Fit.

    • Considerations in Testing for Inherited Breast Cancer Predisposition in the Era of Personalized Medicine.
    • Powers B, Pal T, Laronga C.
    • Surg Oncol Clin N Am. 2018 Jan;27(1):1-22. doi: 10.1016/j.soc.2017.08.003.
    • Review
    • Breast Cancer Disparities: How Can We Leverage Genomics to Improve Outcomes?
    • Davis MB, Newman LA.
    • Surg Oncol Clin N Am. 2018 Jan;27(1):217-234. doi: 10.1016/j.soc.2017.07.009.
    • Review
    • The Rise and Fall and Rise of Linkage Analysis as a Technique for Finding and Characterizing Inherited Influences on Disease Expression.
    • Lipner EM, Greenberg DA.
    • Methods Mol Biol. 2018;1706:381-397. doi: 10.1007/978-1-4939-7471-9_21.
    • Review
    • The Preventive Intervention of Hereditary Breast Cancer.
    • Cao A, Huang L, Shao Z.
    • Adv Exp Med Biol. 2017 [2017 Dec 28];1026:41-57. doi: 10.1007/978-981-10-6020-5_3.
    • Review
    • BRCA 1 and 2.
    • Casaubon JT, Regan JP.
    • StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017-. 2017 Dec 8.
    • Identification and management of familial breast cancer in Austria.
    • Singer CF, Tan YY, Rappaport C.
    • Horm Mol Biol Clin Investig. 2017 Nov 30;32(2). pii: /j/hmbci.2017.32.issue-2/hmbci-2017-0025/hmbci-2017-0025.xml. doi: 10.1515/hmbci-2017-0025.
    • Review
    • Genetics of Breast and Gynecologic Cancers (PDQ®): Health Professional Version.
    • PDQ Cancer Genetics Editorial Board.
    • PDQ Cancer Information Summaries [Internet]. Bethesda, MD: National Cancer Institute. Updated 2017 Nov 30. Accessed 2017 Dec 8.
    • Testing for BRCA1/2 Mutations.
    • Sefton P.
    • JAMA. 2017 Nov 28;318(20):2054. doi: 10.1001/jama.2017.17280.
    • International Szent-Györgyi Prize for Progress in Cancer Research: basic and translational research recognition : Mary-Claire King received the 2016 Prize for her pioneering research that demonstrated the first evidence of genetic predisposition to breast cancer.
    • Hartmann H, Zhao J, Ba S.
    • Chin J Cancer. 2017 Nov 21;36(1):92. doi: 10.1186/s40880-017-0258-8.
    • Non-BRCA1/2 Breast Cancer Susceptibility Genes: A New Frontier with Clinical Consequences for Plastic Surgeons.
    • Frey JD, Salibian AA, Schnabel FR, Choi M, Karp NS.
    • Plast Reconstr Surg Glob Open. 2017 Nov 20;5(11):e1564. doi: 10.1097/GOX.0000000000001564. eCollection 2017 Nov.
    • BRCA mutations in the manifestation and treatment of ovarian cancer.
    • Pan Z, Xie X.
    • Oncotarget. 2017 May 30;8(57):97657-97670. doi: 10.18632/oncotarget.18280. eCollection 2017 Nov 14.
    • Current and future role of genetic screening in gynecologic malignancies.
    • Ring KL, Garcia C, Thomas MH, Modesitt SC.
    • Am J Obstet Gynecol. 2017 Nov;217(5):512-521. doi: 10.1016/j.ajog.2017.04.011. Epub 2017 Apr 12.
    • Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.
    • Hoskins PJ, Gotlieb WH.
    • CA Cancer J Clin. 2017 Nov;67(6):493-506. doi: 10.3322/caac.21408. Epub 2017 Sep 7.
    • Ovarian Cancer Prevention, Screening, and Early Detection: Report From the 11th Biennial Ovarian Cancer Research Symposium.
    • Chien J, Poole EM.
    • Int J Gynecol Cancer. 2017 Nov;27(9S Suppl 5):S20-S22. doi: 10.1097/IGC.0000000000001118.
    • Conference report
    • Genetic Testing: Challenges and Changes in Testing for Hereditary Cancer Syndromes.
    • King E, Mahon SM.
    • Clin J Oncol Nurs. 2017 Oct 1;21(5):589-598. doi: 10.1188/17.CJON.589-598.
    • Germline Genetic Variants with Implications for Disease Risk and Therapeutic Outcomes.
    • Pasternak AL, Ward KM, Luzum JA, Ellingrod VL, Hertz DL.
    • Physiol Genomics. 2017 Oct 1;49(10):567-581. doi: 10.1152/physiolgenomics.00035.2017. Epub 2017 Sep 8.
    • Review
    • Integrating surgery and genetic testing for the modern surgeon.
    • Caso R, Beamer M, Lofthus AD, Sosin M.
    • Ann Transl Med. 2017 Oct;5(20):399. doi: 10.21037/atm.2017.06.50.
    • Prognostic impact of germline mutations in inherited cancer syndromes.
    • Corso G, Feroce I, Intra M, Veronesi P, Sacchini V, Bonanni B, Galimberti V.
    • Future Oncol. 2017 Oct;13(24):2125-2127. doi: 10.2217/fon-2017-0296. Epub 2017 Oct 6.
    • Editorial, Review
    • Impact of germline and somatic BRCA1/2 mutations: Tumor spectrum and detection platforms.
    • Wu H, Wu X, Liang Z.
    • Gene Ther. 2017 Oct;24(10):601-609. doi: 10.1038/gt.2017.73. Epub 2017 Aug 3.
    • Review
    • Breast cancer genetics in young women: What do we know?
    • Gómez-Flores-Ramos L, Álvarez-Gómez RM, Villarreal-Garza C, Wegman-Ostrosky T, Mohar A.
    • Mutat Res. 2017 Oct;774:33-45. doi: 10.1016/j.mrrev.2017.08.001. Epub 2017 Aug 25.
    • Review
    • The Evolution, Functions and Applications of the Breast Cancer Genes BRCA1 and BRCA2.
    • Pfeffer CM, Ho BN, Singh ATK.
    • Cancer Genomics Proteomics. 2017 Sep-Oct;14(5):293-298.
    • Your Genes: Getting the Best Fit.
    • Tempero M.
    • J Natl Compr Canc Netw. 2017 Sep;15(9):1083. doi: 10.6004/jnccn.2017.0152.

    Related:

    Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.

    Commentary: Your Genes: One Size Doesn't Fit All (Journal of the National Comprehensive Cancer Network)

    • Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome.
    • Committee on Practice Bulletins–Gynecology, Committee on Genetics, Society of Gynecologic Oncology.
    • Obstet Gynecol. 2017 Sep;130(3):e110-e126. doi: 10.1097/AOG.0000000000002296.
    • Guidelines

    Related:

    Summary:

    Practice Bulletin No. 182 Summary: Hereditary Breast and Ovarian Cancer Syndrome.

    • Committee Opinion No. 716: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.
    • Committee on Gynecologic Practice, Society of Gynecologic Oncology.
    • Obstet Gynecol. 2017 Sep;130(3):e146-e149. doi: 10.1097/AOG.0000000000002299.

    Related:

    Summary:

    Committee Opinion No. 716 Summary: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.

    • Breast Cancer Genetics for Plastic Surgeons.
    • McInerney NM, Narod S, Metcalfe K, Semple J, Brown MH.
    • Plast Reconstr Surg. 2017 Sep;140(3):455-460. doi: 10.1097/PRS.0000000000003577.
    • Review
    • [The progress and prospect of application of genetic testing technology-based gene detection technology in the diagnosis and treatment of hereditary cancer].
    • He JX, Jiang YF.
    • Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Aug 6;51(8):772-776. doi: 10.3760/cma.j.issn.0253-9624.2017.08.022.
    • Review; Article in Chinese; Abstract in English, Chinese
    • Barriers and Facilitating Factors for Implementation of Genetic Services: A Public Health Perspective.
    • Cornel MC, van El CG.
    • Front Public Health. 2017 Aug 4;5:195. doi: 10.3389/fpubh.2017.00195. eCollection 2017.
    • BRCA mutation in ovarian cancer: testing, implications and treatment considerations.
    • Neff RT, Senter L, Salani R.
    • Ther Adv Med Oncol. 2017 Aug;9(8):519-531. doi: 10.1177/1758834017714993. Epub 2017 Jun 19.
    • Inherited mutations in DNA repair genes and cancer risk.
    • Romero-Laorden N, Castro E.
    • Curr Probl Cancer. 2017 Jul - Aug;41(4):251-264. doi: 10.1016/j.currproblcancer.2017.02.009. Epub 2017 Mar 22.
    • Review
    • BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management.
    • Lee MV, Katabathina VS, Bowerson ML, Mityul MI, Shetty AS, Elsayes KM, Balachandran A, Bhosale PR, McCullough AE, Menias CO.
    • Radiographics. 2017 Jul-Aug;37(4):1005-1023. doi: 10.1148/rg.2017160144. Epub 2017 May 26.
    • Review
    • Genetics of gynaecological cancers.
    • Constantinou P, Tischkowitz M.
    • Best Pract Res Clin Obstet Gynaecol. 2017 Jul;42:114-124. doi: 10.1016/j.bpobgyn.2017.01.004. Epub 2017 Jan 24.
    • Review
    • European/U.S. Comparison and Contrasts in Ovarian Cancer Screening and Prevention in a High-Risk Population.
    • Mourits MJ, de Bock GH.
    • Am Soc Clin Oncol Educ Book. [Presented Sunday, June 4, 2017.] 2017;37:124-127. doi: 10.14694/EDBK_180330.
    • [Breast Cancer in Young Women - Correlation of Clinical Histomorphological, and Molecular-genetic Features of Breast Carcinoma in Women Younger than 35 Years of Age].
    • Metelková A, Skálová A, Fínek J.
    • Klin Onkol. 2017 Summer;30(3):202-209. doi: 10.14735/amko2017202.
    • Breast cancer and genomic testing.
    • Liedtke C, Kolberg HC.
    • Br J Surg. 2017 Jun;104(7):799-801. doi: 10.1002/bjs.10513. Epub 2017 Mar 16.
    • Highlights of the San Antonio Breast Cancer Symposium 2016.
    • Benson JR, Jatoi I.
    • Future Oncol. 2017 Jun;13(15):1291-1295. doi: 10.2217/fon-2017-0088. Epub 2017 Jun 26.
    • Therapeutic and Preventive Implications of Moonshot in Hereditary Cancer Syndromes.
    • Diab O, Chintalacheruvu LM, Lynch HT.
    • JAMA Oncol. 2017 May 1;3(5):592-593. doi: 10.1001/jamaoncol.2016.3046.
    • Commentary
    • Imaging of Hereditary Tumors of the Female Genital System.
    • Rothan SM, Menias CO, ElGuindy YM, Jensen CT, Shaaban A, Bhosale P, Lee MV, Katabathina VS, Elsayes KM.
    • J Comput Assist Tomogr. 2017 May/Jun;41(3):364-375. doi: 10.1097/RCT.0000000000000558.
    • Review
    • European/U.S. Comparison and Contrasts in Ovarian Cancer Screening and Prevention in a High-Risk Population.
    • Mourits MJ, de Bock GH.
    • Am Soc Clin Oncol Educ Book. 2017 May;(37):124-127. doi: 10.1200/EDBK_180330.
    • Hereditary Ovarian Cancer and Risk Reduction.
    • Andrews L, Mutch DG.
    • Best Pract Res Clin Obstet Gynaecol. 2017 May;41:31-48. doi: 10.1016/j.bpobgyn.2016.10.017. Epub 2017 Jan 17.
    • Review
    • [Hereditary breast and ovarian cancer].
    • Lax SF.
    • Pathologe. 2017 May;38(3):149-155. doi: 10.1007/s00292-017-0298-5.
    • Next Generation Sequencing and Multi-Gene Panel Testing: Implications for the Oncology Nurse.
    • Kelly PA.
    • Semin Oncol Nurs. 2017 May;33(2):208-218. doi: 10.1016/j.soncn.2017.02.007. Epub 2017 Apr 5.
    • Review
    • An alternative model for (breast) cancer predisposition.
    • Teugels E, De Brakeleer S.
    • NPJ Breast Cancer. 2017 Apr 17;3:13. doi: 10.1038/s41523-017-0017-7. eCollection 2017.
    • BRCA mutation genetic testing implications in the United States.
    • Bayraktar S, Arun B.
    • Breast. 2017 Feb;31:224-232. doi: 10.1016/j.breast.2016.11.021. Epub 2016 Dec 6.
    • Pathogenesis and heterogeneity of ovarian cancer.
    • Kroeger PT Jr, Drapkin R.
    • Curr Opin Obstet Gynecol. 2017 Feb;29(1):26-34. doi: 10.1097/GCO.0000000000000340.
    • [Molecular Diagnosis and Treatment of HBOC Syndrome].
    • Miki Y.
    • Gan To Kagaku Ryoho. 2017 Feb;44(2):102-106.
    • Review, [Article in Japanese]
    • [Clinical Management of HBOC in Our Hospital].
    • Nomura H, Takeshima N.
    • Gan To Kagaku Ryoho. 2017 Feb;44(2):116-120.
    • [Article in Japanese]
    • BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.
    • Godet I, Gilkes DM.
    • Integr Cancer Sci Ther. 2017 Feb;4(1). doi: 10.15761/ICST.1000228. Epub 2017 Feb 27.
    • [Can new molecular profiles in epithelial ovarian cancer modify therapeutics?]
    • Lavoué V, Rousselin A, Delplanque S, Pinsard M, Henno S, Foucher F, Levêque J, de la Motte Rouge T.
    • J Gynecol Obstet Hum Reprod. 2017 Feb;46(2):107-112. doi: 10.1016/j.jogoh.2016.09.002. Epub 2017 Jan 30.
    • Review, [Article in French]
    • Understanding breast cancer - The long and winding road.
    • Lukong KE.
    • BBA Clin. 2017 Jan 27;7:64-77. doi: 10.1016/j.bbacli.2017.01.001. eCollection 2017.
    • Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelines.
    • Cruz-Correa M, Pérez-Mayoral J, Dutil J, Echenique M, Mosquera R, Rivera-Román K, Umpierre S, Rodriguez-Quilichini S, Gonzalez-Pons M, Olivera MI, Pardo S; Puerto Rico Clinical Cancer Genetics Consortia.
    • Hered Cancer Clin Pract. 2017 Jan 21;15:3. doi: 10.1186/s13053-017-0063-z. eCollection 2017.
    • "Angelina Jolie Effect”: What Should I Know About Hereditary Cancer and Testing?
    • Erica Ramos.
    • NSGC Blog. 2017 Jan 18.
    • Blog post
    • Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.
    • Li H, Feng B, Miron A, Chen X, Beesley J, Bimeh E, Barrowdale D, John EM, Daly MB, Andrulis IL, Buys SS, Kraft P; kConFab investigators, Thorne H, Chenevix-Trench G, Southey MC, Antoniou AC, James PA, Terry MB, Phillips KA, Hopper JL, Mitchell G, Goldgar DE.
    • Genet Med. 2017 Jan;19(1):30-35. doi: 10.1038/gim.2016.43. Epub 2016 May 12.
    • Breast Cancer Epidemiology, Prevention, and Screening.
    • Winters S, Martin C, Murphy D, Shokar NK.
    • Prog Mol Biol Transl Sci. 2017;151:1-32. doi: 10.1016/bs.pmbts.2017.07.002. Epub 2017 Oct 10.
    • Review
    • BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer.
    • Petrucelli N, Daly MB, Pal T.
    • GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. 1998 Sep 04 [updated 2016 Dec 15].
    • Breast Cancer: Genetics and Risk Assessment.
    • Tejada-Bergés T.
    • Clin Obstet Gynecol. 2016 Dec;59(4):673-687.
    • CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control.
    • Rodriguez JL, Thomas CC, Massetti GM, Duquette D, Avner L, Iskander J, Khoury MJ, Richardson LC.
    • MMWR Morb Mortal Wkly Rep. 2016 Nov 25;65(46):1291-1294. doi: 10.15585/mmwr.mm6546a3.
    • New Toolkit Can Help Debunk Myths About Genetic Testing for Gynecologic Cancer.
    • Casey A.
    • Cure. 2016 Oct 27.

    Related:

    Review. Toolkit: 2016 Genetics Toolkit (Society of Gynecologic Oncology)

    • Be a “Know-It-All” About Your Breast Cancer Risk.
    • Mary Freivogel.
    • NSGC Blog. 2016 Oct 26.
    • Blog post
    • Genetic Tests That Make a Difference After a Breast Cancer Diagnosis.
    • Marisa C. Weiss
    • U.S. News and World Report. Health Care. Oct. 24, 2016.
    • Assessing, Counseling, and Treating Patients at High Risk for Breast Cancer.
    • Clifford E, Hughes KS, Roberts M, Pirzadeh-Miller S, McLaughlin SA.
    • Ann Surg Oncol. 2016 Oct;23(10):3128-32. doi: 10.1245/s10434-016-5399-5. Epub 2016 Jul 11.
    • Review
    • Identification and management of women with a family history of breast cancer: Practical guide for clinicians.
    • Heisey R, Carroll JC.
    • Can Fam Physician. 2016 Oct;62(10):799-803.
    • Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer.
    • Cobain EF, Milliron KJ, Merajver SD.
    • Semin Oncol. 2016 Oct;43(5):528-535. doi: 10.1053/j.seminoncol.2016.10.001. Epub 2016 Oct 8.
    • Review
    • Genetic predisposition in gynecologic cancers.
    • Daniels MS, Lu KH.
    • Semin Oncol. 2016 Oct;43(5):543-547. doi: 10.1053/j.seminoncol.2016.08.005. Epub 2016 Sep 20.
    • Review
    • Strategies for clinical implementation of screening for hereditary cancer syndromes.
    • Heald B, Marquard J, Funchain P.
    • Semin Oncol. 2016 Oct;43(5):609-614. doi: 10.1053/j.seminoncol.2016.08.008. Epub 2016 Sep 21.
    • Review
    • Pandora’s DNA: Tracing the Breast Cancer Genes Through History, Science, and One Family Tree
    • Robertson C.
    • Book Review, Perspectives in Genetic Counseling, Volume 38, Number 3, p. 16. 2016 Qtr 3.
    • Translating genetics beyond bench and bedside: A comparative perspective on health care infrastructures for 'familial' breast cancer.
    • Aarden E.
    • Appl Transl Genom. 2016 Sep 29;11:48-54. doi: 10.1016/j.atg.2016.09.001. eCollection 2016.
    • Why I Won’t Get the Genetic Test for Breast Cancer.
    • Cynthia Graber.
    • Wired. Science. 2016 Sep 27.

    Related:

    News: Genetic testing has become more affordable and available. Should you get it? (FORCE)

    • BRCA to the future: towards best testing practice in the era of personalised healthcare.
    • Capoluongo E.
    • Eur J Hum Genet. 2016 Sep;24 Suppl 1:S1-2. doi: 10.1038/ejhg.2016.92.
    • New challenges for BRCA testing: a view from the diagnostic laboratory.
    • Wallace AJ.
    • Eur J Hum Genet. 2016 Sep;24 Suppl 1:S10-8. doi: 10.1038/ejhg.2016.94.
    • Ovarian cancer.
    • Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY.
    • Nat Rev Dis Primers. 2016 Aug 25;2:16061. doi: 10.1038/nrdp.2016.61.
    • Review
    • Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management.
    • Kleibl Z, Kristensen VN.
    • Breast. 2016 Aug;28:136-44. doi: 10.1016/j.breast.2016.05.006. Epub 2016 Jun 16.
    • Review

    Related:

    Comments on NSGC Discussion Forum Cancer SIG

    Subject: CHEK2 and adjuvant radiation therapy

    • Methods to identify BRCA testing in claims data.
    • Lynch J, Berse B.
    • Am J Obstet Gynecol. 2016 Jul;215(1):133-4. doi: 10.1016/j.ajog.2016.03.049. Epub 2016 Apr 12.

    Related:

    Letter / Reply:

    Reply.

    • [Latest international guidelines for screening, prevention and treatment of familial breast cancer - implications for the relevant practice in Hungary].
    • Romics L, Kocsis J, Ormándi K, Molnár BÁ.
    • Orv Hetil. 2016 Jul;157(28):1117-25. doi: 10.1556/650.2016.30473.
    • Diagnosis and Management of Ovarian Cancer.
    • Doubeni CA, Doubeni AR, Myers AE.
    • Am Fam Physician. 2016 Jun 1;93(11):937-44.
    • Genetic testing for hereditary breast cancer in Asia-moving forward.
    • Kwong A.
    • Chin Clin Oncol. 2016 Jun;5(3):47. doi: 10.21037/cco.2016.05.11.
    • [BRCA mutations: from Angelina Jolie to specific therapies].
    • Lopez VA, Stravodimou A, Unger S, Perey L, Zaman K.
    • Rev Med Suisse. 2016 May 18;12(519):973-4, 976-7.
    • Review, [Article in French]
    • Here’s what men need to know about the Angelina Jolie ‘breast-cancer gene’.
    • Laurie McGinley.
    • Washington Post. To Your Health. 2016 May 17.
    • Defective ‘breast cancer’ genes aren’t just dangerous for women. They’re also linked to aggressive cancer in men.
    • Laurie McGinley.
    • Washington Post. To Your Health. 2016 May 15.
    • Angelina's Impact: Genetic Counselors Share.
    • [No author given]
    • My Gene Counsel. 2016 May 14.
    • Angelina's Impact: Advocates Share.
    • [No author given]
    • My Gene Counsel. 2016 May 14.
    • Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital.
    • Palmero EI, Galvão HC, Fernandes GC, Paula AE, Oliveira JC, Souza CP, Andrade CE, Romagnolo LG, Volc S, C Neto M, Sabato C, Grasel R, Mauad E, Reis RM, Michelli RA.
    • Genet Mol Biol. 2016 May 13;39(2):168-177. doi: 10.1590/1678-4685-GMB-2014-0364.
    • Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention.
    • Karakasis K, Burnier JV, Bowering V, Oza AM, Lheureux S.
    • Front Oncol. 2016 May 11;6:119. doi: 10.3389/fonc.2016.00119. eCollection 2016.
    • Evolving Approaches in Research and Care for Ovarian Cancers: A Report From the National Academies of Sciences, Engineering, and Medicine.
    • Levine DA, Karlan BY, Strauss JF 3rd.
    • JAMA. 2016 May 10;315(18):1943-4. doi: 10.1001/jama.2016.2640.
    • Women's Health Issues for BRCA Mutation Carriers.
    • Sabatini ME, Ellisen LW.
    • Am Soc Clin Oncol Educ Book. 2016 May;(36):14-17. doi: 10.1200/EDBK_100001.
    • More People Seek Genetic Testing, But There Aren't Enough Counselors.
    • Todd Bookman.
    • NPR. Morning Edition. 2016 Apr 18.
    • NCCN Adds New Gene Mutations to Consider in Women's Cancers.
    • Fran Lowry.
    • Medscape Medical News. Oncology. National Comprehensive Cancer Network (NCCN) 21st Annual Conference. 2016 Apr 4.
    • The genetic prediction of risk for gynecologic cancers.
    • Randall LM, Pothuri B.
    • Gynecol Oncol. 2016 Apr;141(1):10-6. doi: 10.1016/j.ygyno.2016.03.007.
    • Review
    • Bad Luck Or Bad Genes? Dealing With BRCA And 'A Cancer In The Family'.
    • Terry Gross, Theodora Ross.
    • NPR. Fresh Air. Health. 2016 Mar 14.
    • Genetics of triple-negative breast cancer: Implications for patient care.
    • Afghahi A, Telli ML, Kurian AW.
    • Curr Probl Cancer. 2016 Mar - Aug;40(2-4):130-140. doi: 10.1016/j.currproblcancer.2016.09.007. Epub 2016 Sep 23.
    • Review
    • Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.
    • Hall MJ, Obeid EI, Schwartz , Mantia-Smaldone G, Forman AD, Daly MB.
    • Gynecol Oncol. 2016 Mar;140(3):565-74. doi: 10.1016/j.ygyno.2016.01.019. Epub 2016 Jan 23.
    • Review
    • Should you take a genetic test? Here’s what expert counselors advise.
    • Patrick Skerrett
    • STAT. 2016 Feb 12.
    • Cancer predisposition genes: molecular mechanisms and clinical impact on personalized cancer care: examples of Lynch and HBOC syndromes.
    • Wang Q.
    • Acta Pharmacol Sin. 2016 Feb;37(2):143-9. doi: 10.1038/aps.2015.89. Epub 2015 Nov 30.
    • [Hereditary Breast and Ovarian Cancer--From the Gynecological Viewpoint].
    • Ohsumi S.
    • Gan To Kagaku Ryoho. 2016 Feb;43(2):189-92.
    • [Article in Japanese]
    • Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
    • Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S.
    • J Natl Compr Canc Netw. 2016 Feb;14(2):153-62.

    Related:

    Comments on NSGC Discussion Forum Cancer SIG

    Subject: NCCN High-Risk Breast-Ovarian Guidelines 1.2016

    • Breast Cancer Genetic Counseling: A Surgeon's Perspective.
    • Agnese DM, Pollock RE.
    • Front Surg. 2016 Jan 28;3:4. doi: 10.3389/fsurg.2016.00004. eCollection 2016.
    • Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
    • Modell SM, Greendale K, Citrin T, Kardia SL.
    • Healthcare (Basel). 2016 Jan 27;4(1). pii: E14. doi: 10.3390/healthcare4010014.
    • Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet.
    • Ngeow J, Eng C.
    • NPJ Genom Med. 2016 Jan 13;1:15006. doi: 10.1038/npjgenmed.2015.6. eCollection 2016.
    • Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine.
    • Cragun D, Lewis C, Camperlengo L, Pal T.
    • Healthcare (Basel). 2016 Jan 8;4(1). pii: E6. doi: 10.3390/healthcare4010006.
    • Women's Health Issues for BRCA Mutation Carriers.
    • Sabatini ME, Ellisen LW.
    • Am Soc Clin Oncol Educ Book. 2016;35:14-17. doi: 10.14694/EDBK_100001.

    Related:

    Comments from NSGC Discussion Forum Cancer SIG

    Subject: hormonal birth control with ATM mutations?

    • Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic Medicine.
    • Silverstein A, Sood R, Costas-Chavarri A.
    • Int J Breast Cancer. 2016;2016:4792865. doi: 10.1155/2016/4792865. Epub 2016 Jun 16.
    • 2016 Genetics Toolkit
    • Society of Gynecologic Oncology
    • Society of Gynecologic Oncology. 2016.

    Related:

    News: New Toolkit Can Help Debunk Myths About Genetic Testing for Gynecologic Cancer. (Cure)

    • Ovarialcancer är på många sätt en heterogen sjukdom.
    • Malander S, Hjerpe E, Carlson J, Borg Å.
    • Lakartidningen. 2015 Dec 8;112. pii: DIUR.
    • Genetic Testing: What It Means for You and Your Family.
    • Ora Gordon.
    • Everyday Health. 2015 Dec 2.
    • [Hereditary Breast and Ovarian Cancer Syndrome].
    • Petráková K, Palácová M, Schneiderová M, Standara M.
    • Klin Onkol. 2015 Winter;29 Suppl 1:14-21.
    • Review, [Article in Czech]
    • SEOM clinical guidelines in Hereditary Breast and ovarian cancer.
    • Llort G, Chirivella I, Morales R, Serrano R, Sanchez AB, Teulé A, Lastra E, Brunet J, Balmaña J, Graña B; SEOM Hereditary Cancer Working Group.
    • Clin Transl Oncol. 2015 Dec;17(12):956-61. doi: 10.1007/s12094-015-1435-3. Epub 2015 Dec 15.
    • Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.
    • Weiderpass E, Tyczynski JE.
    • Mol Diagn Ther. 2015 Dec;19(6):351-64. doi: 10.1007/s40291-015-0168-x.
    • Hereditary Cancer, Insurance, and Your Legal Rights.
    • Anya Prince.
    • FORCE. Be Empowered Webinars. 2015 Nov 18.
    • Discussion: The Next Big Things in the BRCA World.
    • [No author given].
    • My Gene Counsel. 2015 Nov 4.
    • Genital Cancers in Women: Ovarian Cancer.
    • Kuznia AL, Roett MA.
    • FP Essent. 2015 Nov;438:24-30.
    • The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011-2014.
    • Trivers KF, Rodriguez JL, Cox SL, Crane BE, Duquette D.
    • Healthcare (Basel). 2015 Oct 15;3(4):948-63. doi: 10.3390/healthcare3040948.
    • Breast Cancer Risk: What Women – and Men – Need to Know.
    • Joy Larsen Haidle.
    • NSGC Blog. 2015 Oct 1.
    • Ovarian cancer: Ensuring early diagnosis.
    • Slatnik CL, Duff E.
    • Nurse Pract. 2015 Sep 13;40(9):47-54. doi: 10.1097/01.NPR.0000450742.00077.a2.
    • Hereditary Breast Cancer Syndromes: Molecular Pathogenesis and Diagnostics.
    • Vos S, Van der Groep P, Van der Wall E, Van Diest PJ.
    • eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net. doi: 10.1002/9780470015902.a0005375. 2015 Sep.
    • Review
    • Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.
    • Stuckey AR, Onstad MA.
    • Am J Obstet Gynecol. 2015 Aug;213(2):161-5. doi: 10.1016/j.ajog.2015.03.003. Epub 2015 Mar 3.
    • Review
    • Management of women at high risk of hereditary breast cancer in the Veneto Regional Program for Prevention.
    • Del Sole A, Cinquetti S, Fedato C, Montagna M, Russo F, Sbrogiò LG, Zorzi M.
    • Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):99-101.
    • Breast cancer in women in their thirties (2007-2013): A retrospective review.
    • Arleo EK, Reichman M, Dashevsky BZ, Babagbemi K, Drotman M.
    • Breast Dis. 2015 Jun 1;35(2):87-93. doi: 10.3233/BD-150400.
    • Breast Cancer Risk Gene Discovery: Opportunities and Challenges.
    • Fabienne Lesueur.
    • Current Genetic Medicine Reports 3(2):8-91. 2015 Jun.
    • Review
    • Committee opinion no. 634: Hereditary cancer syndromes and risk assessment.
    • [No authors listed]
    • Obstet Gynecol. 2015 Jun;125(6):1538-43. doi: 10.1097/01.AOG.0000466373.71146.51.

    Related:

    Press: ACOG Issues Guidelines for Hereditary Cancer Screening. (Medscape Oncology)

    • Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer.
    • Aloraifi F, Boland MR, Green AJ, Geraghty JG.
    • Surg Oncol. 2015 Jun;24(2):100-9. doi: 10.1016/j.suronc.2015.04.003. Epub 2015 Apr 13.
    • Review
    • Two Women, Two Results: The Agonizing Wait for Cancer Gene Tests.
    • [No author given]
    • NBC Nightly News. 2015 May 19.
    • Mary-Claire King on Inherited Breast/Ovarian Cancer.
    • Dan Koboldt.
    • MassGenomics. 2015 May 14.
    • The Consequences of a BRCA Mutation in Women.
    • Famorca-Tran J, Roux G.
    • J Adv Pract Oncol. 2015 May-Jun;6(3):194-210. Epub 2015 May 1.
    • Genetic tests to identify risk for breast cancer.
    • Lynch JA, Venne V, Berse B.
    • Semin Oncol Nurs. 2015 May;31(2):100-7. doi: 10.1016/j.soncn.2015.02.007. Epub 2015 Feb 26.
    • Review
    • With BRCA genetic testing on rise, insurers balk.
    • Marie McCullough.
    • Philly.com. 2015 Apr 19.
    • 20 Years Since BRCA2: Where Are We Now in Cancer Screening?
    • Eric J. Topol, Nazneen Rahman.
    • Medscape, Eric Topol on Medscape, Medscape One-on-One. 2015 Apr 13.
    • Discussion: Sex After Oophorectomy, Hysterectomy.
    • Mel Majoros, Ellen T. Matloff, Amy Byer Shainman, Georgia Hurst.
    • My Gene Counsel / The Cancer Warrior. 2015 May 5.
    • Angelina Jolie's message was 'choose what's right for you,' and experts agree.
    • Christine Mai-Duc
    • LA Times, 2015 Mar 24.
    • The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer.
    • Newman LA, Reis-Filho JS, Morrow M, Carey LA, King TA.
    • Ann Surg Oncol. 2015 Mar;22(3):874-82. doi: 10.1245/s10434-014-4279-0. Epub 2014 Dec 20.
    • Review
    • Personalized assessment and management of women at risk for breast cancer in North America.
    • Pruthi S, Heisey R, Bevers T.
    • Womens Health (Lond Engl). 2015 Mar;11(2):213-23; quiz 223-4. doi: 10.2217/whe.14.79.
    • Breast cancer prevention.
    • Euhus DM, Diaz J.
    • Breast J. 2015 Jan-Feb;21(1):76-81. doi: 10.1111/tbj.12352. Epub 2014 Nov 20.
    • Breast Cancer Susceptibility Genes.
    • Apostolou P, Vratimos A, Fostira F.
    • eLS. 2015 Jan. doi: 10.1002/9780470015902.a0025847.
    • Review
    • Hereditary breast cancer syndromes and genetic testing.
    • Rich TA, Woodson AH, Litton J, Arun B.
    • J Surg Oncol. 2015 Jan;111(1):66-80. doi: 10.1002/jso.23791. Epub 2014 Nov 7.
    • Review
    • Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes.
    • Toss A, Tomasello C, Razzaboni E, Contu G, Grandi G, Cagnacci A, Schilder RJ, Cortesi L.
    • Biomed Res Int. 2015;2015:341723. Epub 2015 May 17.
    • [Triple Negative Breast Cancer].
    • Navrátil J, Fabian P, Palácová M, Petráková K, Vyzula R, Svoboda M.
    • Klin Onkol. 2015;28(6):405-15.
    • Review, [Article in Czech]
    • Unknown significance.
    • Couzin-Frankel J.
    • Science. 2014 Dec 5;346(6214):1167-70. doi: 10.1126/science.346.6214.1167.

    Related:

    Press: Feature: Peering into my genome (Science)

    • The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future.
    • Al Bakir M, Gabra H.
    • Br Med Bull. 2014 Dec;112(1):57-69. doi: 10.1093/bmb/ldu034.
    • Breast Cancer in Adolescent and Young Adult Women.
    • Gewefel H, Salhia B.
    • Clin Breast Cancer. 2014 Dec;14(6):390-395. doi: 10.1016/j.clbc.2014.06.002. Epub 2014 Jun 23.
    • Review
    • Breast cancer genes: looking for BRACA's lost brother.
    • Cornejo-Moreno BA, Uribe-Escamilla D, Salamanca-Gómez F.
    • Isr Med Assoc J. 2014 Dec;16(12):787-92.
    • BRCA genetic testing: State of the science.
    • Kelly PA, Connors LM.
    • Nurse Pract. 2014 Nov 16;39(11):9. doi: 10.1097/01.NPR.0000456025.48460.c5.
    • Letter, Comment

    Related:

    Review:

    Genetic testing for BRCA1 and BRCA2 genes.

    • Hereditary breast and ovarian cancer syndrome: Considering the complexities.
    • Senter L.
    • Curr Probl Cancer. 2014 Nov-Dec;38(6):226-34. doi: 10.1016/j.currproblcancer.2014.10.003. Epub 2014 Oct 31.
    • Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.
    • Bando H.
    • Breast Cancer. 2014 Nov;21(6):656-63. doi: 10.1007/s12282-013-0477-z. Epub 2013 Jun 11.
    • [Current Clinical Issues and Recent Trends in Hereditary Breast and Ovarian Cancer in Japan-Genetic Testing for HBOC and Risk-Reducing Surgery].
    • Arai M, Iwase T, Takazawa Y, Takeshima N.
    • Gan To Kagaku Ryoho. 2014 Nov;41(11):1333-9.
    • Review, [Article in Japanese]
    • 20 Years After BRCA: What We’ve Learned About Genetics and Breast Cancer
    • [No author given]
    • Dana-Farber Cancer Institute, 2014 Oct 31
    • Familial breast cancer
    • Helen Hanson
    • GP Onlne, 2014 Oct 24
    • Decoding Breast Cancer Risk: BRCA and Beyond.
    • Lidia Schapira, Leif W. Ellisen.
    • Medscape Oncology, 2014 Oct 16.
    • Hereditary breast cancer: clinical, pathological and molecular characteristics.
    • Larsen MJ, Thomassen M, Gerdes AM, Kruse TA.
    • Breast Cancer (Auckl). 2014 Oct 15;8:145-55. doi: 10.4137/BCBCR.S18715. eCollection 2014.
    • Genetics and BRCA in Primary Care.
    • Katherine Kolor.
    • Medscape Oncology, CDC Expert Commentary, 2014 Oct 13.
    • Natural history of ovarian cancer.
    • Vargas AN.
    • Ecancermedicalscience. 2014 Sep 25;8:465. doi: 10.3332/ecancer.2014.465. eCollection 2014.
    • Pathogenesis, prevention, diagnosis and treatment of breast cancer.
    • Shah R, Rosso K, Nathanson SD.
    • World J Clin Oncol. 2014 Aug 10;5(3):283-98. doi: 10.5306/wjco.v5.i3.283.
    • Genetic testing and familial implications in breast-ovarian cancer families.
    • Oosterwijk JC, de Vries J, Mourits MJ, de Bock GH.
    • Maturitas. 2014 Aug;78(4):252-257. doi: 10.1016/j.maturitas.2014.05.002. Epub 2014 May 9.
    • Review
    • The Role of Testing for BRCA1 and BRCA2 Mutations in Cancer Prevention.
    • McCarthy AM, Armstrong K.
    • JAMA Intern Med. 2014 Jul 1;174(7):1023-4. doi: 10.1001/jamainternmed.2014.1322.
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014.
    • Liedtke C, Thill M, Hanf V, Schütz F; AGO Breast Committee.
    • Breast Care (Basel). 2014 Jul;9(3):189-200. doi: 10.1159/000363591.
    • Personalized therapy for breast cancer.
    • De Abreu FB, Schwartz GN, Wells WA, Tsongalis GJ.
    • Clin Genet. 2014 Jul;86(1):62-7. doi: 10.1111/cge.12381. Epub 2014 Apr 9.
    • Family Cancer Syndromes.
    • [No author given]
    • Cancer.org, Last revised 2014 Jun 25.
    • Genetic testing for BRCA1 and BRCA2 genes.
    • Kessenich CR, Bacher K, Moore PA.
    • Nurse Pract. 2014 Jun 15;39(6):8-10. doi: 10.1097/01.NPR.0000446876.99650.eb.
    • Review

    Related:

    Comment, Letter:

    BRCA genetic testing: State of the science.

    • [Breast cancer update].
    • Armuss A.
    • Versicherungsmedizin. 2014 Jun 1;66(2):68-71.
    • [Article in German]
    • An update on breast cancer screening and prevention.
    • de la Cruz MS, Sarfaty M, Wender RC.
    • Prim Care. 2014 Jun;41(2):283-306. doi: 10.1016/j.pop.2014.02.006. Epub 2014 Mar 27.
    • Review
    • Risk assessment, genetic counseling, and clinical care for hereditary breast cancer.
    • Powers J, Stopfer JE.
    • J Obstet Gynecol Neonatal Nurs. 2014 May-Jun;43(3):361-73. doi: 10.1111/1552-6909.12304. Epub 2014 Apr 1.
    • Review
    • Ovarian Cancer 101 for the Newly Diagnosed.
    • Ilana Cass.
    • FORCE. Be Empowered Webinars. 2014 Apr 11.
    • Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention.
    • Couch FJ, Nathanson KL, Offit K.
    • Science. 2014 Mar 28;343(6178):1466-70. doi: 10.1126/science.1251827.
    • Editorial / Commentary
    • Newly Diagnosed with Breast Cancer: What You Need to Know.
    • Melinda Telli.
    • FORCE. Be Empowered Webinars. 2014 Mar 26.
    • Hereditary gynecologic cancers.
    • Mutch D, Denny L, Quinn M; FIGO Committee on Gynecologic Oncology.
    • Int J Gynaecol Obstet. 2014 Mar;124(3):189-92. doi: 10.1016/j.ijgo.2013.12.001. Epub 2013 Dec 21.
    • Practice Guideline
    • Clinical cancer genetics. Part 2: Breast.
    • Pollock J, Welsh JS.
    • Am J Clin Oncol. 2014 Feb;37(1):86-9. doi: 10.1097/COC.0b013e31823fe657.
    • Review
    • The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.
    • Paul A, Paul S.
    • Front Biosci (Landmark Ed). 2014 Jan 1;19:605-18.
    • Breast cancer genetics: 20 years later.
    • Lubinski J.
    • Clin Genet. 2014 Jan;85(1):5-6. doi: 10.1111/cge.12293. Epub 2013 Nov 18.
    • Editorial / Commentary
    • BRCA-associated ovarian cancer: from molecular genetics to risk management.
    • Girolimetti G, Perrone AM, Santini D, Barbieri E, Guerra F, Ferrari S, Zamagni C, De Iaco P, Gasparre G, Turchetti D.
    • Biomed Res Int. 2014;2014:787143. doi: 10.1155/2014/787143. Epub 2014 Jul 22.
    • Mapping Jewish Identities: Migratory Histories and the Transnational Re-Framing of ‘Ashkenazi BRCA Mutations’ in the UK and Brazil.
    • Mozersky J, Gibbon S.
    • In: Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA. Oxon (UK): Routledge; 2014. Gibbon S, Joseph G, Mozersky J, zur Nieden A, Palfner S, editors. Wellcome Trust–Funded Monographs and Book Chapters.
    • Identification, Evaluation, and Treatment of Patients with Hereditary Cancer Risk within the United States.
    • Cragun D, Pal T.
    • ISRN Oncol. 2013 Dec 22;2013:260847. doi: 10.1155/2013/260847. eCollection 2013.
    • Common breast cancer risk variants in the post-COGS era: a comprehensive review.
    • Maxwell KN, Nathanson KL.
    • Breast Cancer Res. 2013 Dec 20;15(6):212. doi: 10.1186/bcr3591.
    • Increase in breast cancer gene screening: the Angelina Jolie effect.
    • Deborah Kotz.
    • Boston Globe. 2013 Dec 3.
    • [Personalized medicine and breast cancer: anticipatory medicine, prognostic evaluation and therapeutic targeting].
    • Gonçalves A, Moretta J, Eisinger F, Bertucci F.
    • Bull Cancer. 2013 Dec;100(12):1295-310. doi: 10.1684/bdc.2013.1856.
    • Review, [Article in French]
    • Ask Well: Genetic Testing for Breast Cancer.
    • Roni Caryn Rabin.
    • New York Times. Ask Well. 2013 Nov 27.
    • My Cancer Story, My Genes, My Information.
    • Joanna Rudnick.
    • Huffington Post. The Blog. 2013 Nov 19.
    • Pros and cons of screening for BRCA mutations.
    • Howard-McNatt M.
    • N C Med J. 2013 Nov-Dec;74(6):489-90.
    • Hereditary breast and ovarian cancer: lessening the burden.
    • Muggia F, Tommasi S, Lynch H, Paradiso A.
    • Ann Oncol. 2013 Nov;24 Suppl 8:viii5-viii6.
    • Hereditary ovarian and breast cancer: what have we learned?
    • Lynch HT, Snyder C, Casey MJ.
    • Ann Oncol. 2013 Nov;24 Suppl 8:viii83-viii95. doi: 10.1093/annonc/mdt313.
    • Breast cancer in adolescents and young adults: a review with a focus on biology.
    • Tichy JR, Lim E, Anders CK.
    • J Natl Compr Canc Netw. 2013 Sep 1;11(9):1060-9.
    • Review
    • Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.
    • Meaney-Delman D, Bellcross CA.
    • Obstet Gynecol Clin North Am. 2013 Sep;40(3):475-512. doi: 10.1016/j.ogc.2013.05.009. Epub 2013 Jul 30.
    • Review
    • Hereditary breast and ovarian cancer susceptibility genes (Review).
    • Kobayashi H, Ohno S, Sasaki Y, Matsuura M.
    • Oncol Rep. 2013 Sep;30(3):1019-29. doi: 10.3892/or.2013.2541. Epub 2013 Jun 19.
    • Evidence is evidence: an interview with Mary-Claire King. Interviewed by Jane Gitschier.
    • King MC.
    • PLoS Genet. [2013 Sep;]9(9):e1003828. doi: 10.1371/journal.pgen.1003828. Epub 2013 Sep 26.
    • Practical aspects of genetic counseling in breast cancer: Lights and shadows.
    • Christinat A, Pagani O.
    • Breast. 2013 Aug;22(4):375-82. doi: 10.1016/j.breast.2013.04.006. Epub 2013 May 11.
    • Review
    • Management of breast cancer in very young women.
    • Freedman RA, Partridge AH.
    • Breast. 2013 Aug;22 Suppl 2:S176-9. doi: 10.1016/j.breast.2013.07.034.
    • Review
    • In brief: BRCA1 and BRCA2.
    • Foulkes WD, Shuen AY.
    • J Pathol. 2013 Aug;230(4):347-9. doi: 10.1002/path.4205.
    • Review
    • Outsmart Your Genes - Understanding BRCA1/2 Cancer Risk.
    • Huma Q. Rana.
    • Dana-Farber Cancer Institute. 2013 Jul 24.
    • Establishing a program for individuals at high risk for breast cancer.
    • Cadiz F, Kuerer HM, Puga J, Camacho J, Cunill E, Arun B.
    • J Cancer. 2013 Jul 1;4(5):433-46. doi: 10.7150/jca.6481. Print 2013.
    • From integrative genomics to therapeutic targets.
    • Natrajan R, Wilkerson P.
    • Cancer Res. 2013 Jun 15;73(12):3483-8. doi: 10.1158/0008-5472.CAN-12-4717. Epub 2013 Jun 5.
    • Breast cancer genes: beyond BRCA1 and BRCA2.
    • Filippini SE, Vega A.
    • Front Biosci (Landmark Ed). 2013 Jun 1;18:1358-72.
    • Familial Breast Cancer: Classification and Care of People at Risk of Familial Breast Cancer and Management of Breast Cancer and Related Risks in People with a Family History of Breast Cancer.
    • [No author given]
    • National Collaborating Centre for Cancer (UK). 2013 Jun.
    • Breast cancer in the young: role of the geneticist.
    • Woodson AH, Profato JL, Muse KI, Litton JK.
    • J Thorac Dis. 2013 Jun;5(Suppl 1):S19-26. doi: 10.3978/j.issn.2072-1439.2013.04.13.
    • Familial breast cancer (CG164).
    • [No author given]
    • National Institute for Health and Care Excellence. 2013 Jun.
    • BRCA Choices Not Affordable for Many US Women.
    • Roxanne Nelson.
    • Medscape Medical News. Oncology. 2013 May 23.
    • Angelina Jolie’s double mastectomy highlights tough decisions on genetic screening.
    • Deborah Kotz.
    • Boston Globe. 2013 May 14.
    • Genetic Counseling Can Help Women At Risk For Breast Cancer.
    • Melissa Block, Audie Cornish.
    • NPR. All Things Considered. 2013 May 14.
    • Familial Breast Cancer: Genetic Testing.
    • Alabek ML, Farley MN.
    • eLS. John Wiley & Sons Ltd, Chichester. doi: 10.1002/9780470015902.a0005634.pub2. 2013 May.
    • Review
    • An international comparison of male and female breast cancer incidence rates.
    • Ly D, Forman D, Ferlay J, Brinton LA, Cook MB.
    • Int J Cancer. 2013 Apr 15;132(8):1918-26. doi: 10.1002/ijc.27841. Epub 2012 Oct 12.
    • Opportunities for public health communication, intervention, and future research on breast cancer in younger women.
    • Buchanan N, Roland KB, Rodriguez JL, Miller JW, Fairley T.
    • J Womens Health (Larchmt). 2013 Apr;22(4):293-8. doi: 10.1089/jwh.2012.4239. Epub 2013 Mar 20.
    • iCOGS collection provides a collaborative model.
    • Bahcall OG.
    • Nat Genet. 2013 Apr;45(4):343. doi: 10.1038/ng.2592.
    • Introductory article

    Related:

    Blog post: 74 new susceptibility genes found for breast, ovarian and prostate cancer. (Nature Medicine | Spoonful of Medicine)

    • Turning of COGS moves forward findings for hormonally mediated cancers.
    • Sakoda LC, Jorgenson E, Witte JS.
    • Nat Genet. 2013 Apr;45(4):345-8. doi: 10.1038/ng.2587.
    • Introductory article
    • Public health implications from COGS and potential for risk stratification and screening.
    • Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
    • Nat Genet. 2013 Apr;45(4):349-51. doi: 10.1038/ng.2582.
    • Introductory article, Commentary

    Related:

    Press: New Genetic Findings Should Revolutionize Cancer Screening. (Medscape Oncology)

    News: Our commentary in new Nature Genetics special issue. (PHG Foundation)

    • Genetic predisposition syndromes and their management.
    • Euhus DM, Robinson L.
    • Surg Clin North Am. 2013 Apr;93(2):341-62. doi: 10.1016/j.suc.2013.01.005. Epub 2013 Feb 11.
    • Review
    • Miscellaneous syndromes and their management: occult breast cancer, breast cancer in pregnancy, male breast cancer, surgery in stage IV disease.
    • Colfry AJ 3rd.
    • Surg Clin North Am. 2013 Apr;93(2):519-31. doi: 10.1016/j.suc.2012.12.003. Epub 2013 Feb 7.
    • Review
    • [New genetic tests and their clinical utility for cancer screening].
    • Probst-Hensch NM, Brand A.
    • Ther Umsch. 2013 Apr;70(4):251-4; discussion 255-6. doi: 10.1024/0040-5930/a000397.
    • Review, [Article in German]
    • Management of genetic syndromes predisposing to gynecologic cancers.
    • Miesfeldt S, Lamb A, Duarte C.
    • Curr Treat Options Oncol. 2013 Mar;14(1):34-50. doi: 10.1007/s11864-012-0215-3.
    • Review
    • Genetics of Susceptibility to Sporadic Ovarian Cancer.
    • Katabathina VS, Prasad SR.
    • eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net. doi: 10.1002/9780470015902.a0023853. 2013 Feb.
    • BRCA1 and Its Network of Interacting Partners.
    • Christou CM, Kyriacou K.
    • Biology (Basel). 2013 Jan 2;2(1):40-63. doi: 10.3390/biology2010040.
    • Hereditary gynaecological malignancies: advances in screening and treatment.
    • Folkins AK, Longacre TA.
    • Histopathology. 2013 Jan;62(1):2-30. doi: 10.1111/his.12028.
    • Review
    • Ovarian cancer genome.
    • Imyanitov EN.
    • Methods Mol Biol. 2013;1049:3-7. doi: 10.1007/978-1-62703-547-7_1.
    • Review
    • An overview of hereditary breast and ovarian cancer syndrome.
    • Smith EC.
    • J Midwifery Womens Health. 2012 Nov-Dec;57(6):577-84. doi: 10.1111/j.1542-2011.2012.00199.x. Epub 2012 Oct 10.
    • Review
    • Family history and breast cancer.
    • Carroll JC, Heisey R, Warner E.
    • CMAJ. 2012 Sep 4;184(12):1391. doi: 10.1503/cmaj.111670. Epub 2012 Jan 30.
    • [Women with high risk of breast cancer.More bright spots than shadows and many dark spots].
    • Vázquez Caruncho M.
    • Radiologia. 2012 Sep-Oct;54(5):462-4. doi: 10.1016/j.rx.2011.10.004. Epub 2012 Jan 28.
    • [Familial breast cancer and hereditary breast cancer].
    • Masuoka H, Mikami T, Yamazaki K, Shimokawara I, Asaishi K.
    • Nihon Rinsho. 2012 Sep;70 Suppl 7:55-8.
    • [Article in Japanese]
    • [Genetic diagnosis of familial breast cancer].
    • Matsuzaki M, Katagata N, Nomizu T.
    • Nihon Rinsho. 2012 Sep;70 Suppl 7:238-42.
    • [Article in Japanese]
    • Genetics of breast cancer: contribution of BRCA1/2 genes alterations to hereditary predisposition.
    • Branković-Magić M, Dobricić J, Krivokuća A.
    • Vojnosanit Pregl. 2012 Aug;69(8):700-6.
    • Genetic testing by cancer site: breast.
    • Shannon KM, Chittenden A.
    • Cancer J. 2012 Jul-Aug;18(4):310-9. doi: 10.1097/PPO.0b013e318260946f.
    • Review
    • Genetic testing by cancer site: ovary.
    • Weissman SM, Weiss SM, Newlin AC.
    • Cancer J. 2012 Jul-Aug;18(4):320-7. doi: 10.1097/PPO.0b013e31826246c2.
    • Review
    • Managing patients at high risk for hereditary breast cancer: a guide for the practicing physician.
    • Cusack JC Jr, Hughes KS.
    • Ann Surg Oncol. 2012 Jun;19(6):1721-2. doi: 10.1245/s10434-012-2255-0.
    • Hereditary gynecologic cancers: risk assessment, counseling, testing and management.
    • Ballinger LL.
    • Obstet Gynecol Clin North Am. 2012 Jun;39(2):165-81. doi: 10.1016/j.ogc.2012.02.006.
    • Review
    • Young women with breast cancer genes face tough choices.
    • Collier R.
    • CMAJ. 2012 May 15;184(8):E401-2. doi: 10.1503/cmaj.109-4168. Epub 2012 Apr 16.
    • [Hereditary forms of ovarian cancer].
    • de Pauw A, Jolissaint L, Fréneaux P, Rouleau E, Stoppa-Lyonnet D, Buecher B.
    • Bull Cancer. 2012 Apr 1;99(4):453-62. doi: 10.1684/bdc.2012.1544.
    • Review, [Article in French]
    • Translational advances regarding hereditary breast cancer syndromes.
    • Gage M, Wattendorf D, Henry LR.
    • J Surg Oncol. 2012 Apr 1;105(5):444-51. doi: 10.1002/jso.21856.
    • Review
    • Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy.
    • Romero I, Bast RC Jr.
    • Endocrinology. 2012 Apr;153(4):1593-602. doi: 10.1210/en.2011-2123. Epub 2012 Mar 13.
    • [The clinical study of familial breast cancer - now and the problems].
    • Nomizu T, Matsuzaki M, Katagata N, Watanabe F, Akama Y.
    • Gan To Kagaku Ryoho. 2012 Apr;39(4):502-5.
    • [Article in Japanese]
    • [Clinical aspects of familial ovarian cancer - current status and issues in Japan].
    • Sekine M, Yoshihara K, Tanaka K.
    • Gan To Kagaku Ryoho. 2012 Apr;39(4):506-11.
    • [Article in Japanese]
    • Hereditary breast and ovarian cancer.
    • Barks P, Goldgar C.
    • JAAPA. 2012 Mar;25(3):63-5.
    • Review
    • Physician data query (PDQ®) update.
    • [No authors listed]
    • J Natl Cancer Inst. 2012 Feb 8;104(3):176. doi: 10.1093/jnci/djs025. Epub 2012 Jan 23.
    • Integrating breast cancer genetics into clinical practice.
    • Mukherjee A, Rakha EA.
    • Womens Health (Lond Engl). 2012 Jan;8(1):99-112. doi: 10.2217/whe.11.81.
    • Review